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Chapter I. IRON AND THE PLACENTA. 
1-1. General Introduction. 
On earth, iron has presumably played a role in the creation of circumstances 
suitable for life and finely man.",,224 Not until approximately 2000 BC however, 
mankind became aware of the existence of the metal. 
The earliest manuscript iron was mentioned in, originates from Egypt, 1500 BC. Iron 
was used as component of remedies for baldness and pterygium.'14 
Also in Greece iron was introduced which can be deduced from tts role in the 
legend of Iphyclus (1200 BC). 
Via weapons and tools iron became familiar in all layers of society and therefore not 
unlogically, tt became associated wtth war and the god Mars. 
The symptoms of severe (iron deficiency) anaemia were noticed by Lange in 
1554.255 The proposed therapy was: purging, bathing and even bleeding."3 Also 
pregnancy was recommended C'if legally permissable"). 
Although the ancient physicians already suggested that iron was responsible for the 
colour of blood, tt lasted until 1713 before Lemmery and Geoffry proved its 
presence in living tissues.24o 
Since then knowledge on iron metabolism has increased more rapidly wtth a climax 
in the 20th century. In 1832 a relation was shown between reduced iron contents in 
blood and what was called 'Chlorosis' (iron deficiency anaemia).'22 In 1925 tt was 
discovered that in blood not all iron was haemoglobin related.'" 
The possibilities in iron research were extended significantly when "Fe became 
available in 1938. 
In 1946 an iron binding serum protein was discovered, which generally became 
known as 'transferrin' .165,333 Many aspects of this protein have been investigated. 
Iron binding characteristics were explored (reviewed by: Aisen, 1980) and transferrin 
microheterogenetty was discovered.,,103,257 
Other iron binding proteins (like the iron storage protein 'ferritin') were found and 
details of cellular iron uptake, via transferrin receptors and receptor mediated 
endocytosis were elucidated.'84~33,274 
The major discovery of the last decade was the relation between transferrin receptor 
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and ferritin synthesis via structures on their mRNA's, the so called 'Iron Responsive 
Elements'.' 55 
Because of the rapid improvements in the field it is likely that in the (near) future 
major attention will be paid to the molecular biological and genetic aspects of 
transferrin, transferrin receptor and ferritin synthesis despite the fact that many 
questions at the biochemical level (e.g. cellular iron release) are still unanswered. 
1-2. Iron. 
Iron with its molar mass of 56 D plays a key role in a large number of biochemical 
processes and is therefore essential to almost every form of life. In humans iron has 
many functions77 Apart from its function in the transport of oxygen (via 
haemoglobin and myoglobin) iron is essential in electron transport (cytochromes, 
aconitase), catalytic enzyme functions (hydroxylases, mono-oxygenases) and DNA 
synthesis (ribonucleotide reductase).'90 
Of iron two main valence states occur, the divalent ferrous form (Fe') and the 
trivalent ferric form (Fe3.). In solutions and in the presence of oxygen (e.g. the 
human circulation) ferrous iron is rapidly oxidized to the ferric form, which, under 
physiological conditions (pH 7.4), is rapidly hydrolysed to insoluble polymeric 
hydroxides. The equilibrium concentration of free Fe3• is approximately 10.18 moljl 
and the solubility product of Fe(OH)3 only 4x10·3S moljl. 3" Therefore in body fluids 
Fe'· or Fe3• can hardly exist as free ions, they have to be chelated by other 
molecules like proteins. 
The total amount of iron in the human body is 3-5 grams. The majority is found in 
haemoglobin (70 %). Twenty percent is stored in ferritin and only 0.1 % is 
transported bound to transferrin. Intracellularly a small portion is bound by 
structures of low molecular weight.19.'85 
Due to the minimal loss of only 0.5-1.5 mg of iron daily, an avarage uptake of 1 mg 
iron per day is required. The iron stores are balanced by the uptake of iron in the 
duodenum, which can be stimulated by the supplementation of vitamin C.'52.'71.33'.367 
Iron is involved in a wide range of diseases. Deficiency of iron leads to anaemia and 
iron overload to haemochromatosis. In neonatal haemochromatosis a surplus of 
iron can be found in the liver and several other organs, although total body iron 
9 
does not seem to be increased. '.21' Iron is held responsible for the inflammation in 
rheumatoid arthritis,".407 via its role in the production of hydroxyl radicals (Haber-
Weiss reaction) which can damage DNA, proteins and membranes"" It has been 
suggested that iron, via the same mechanism, is involved in Multiple Sclerosis, and 
other diseases of the central nervous system. "5,244 Furthermore ~ reduces fertility, '91 
and in the case of iron deficiency, it may cause preterm deliveries.'39 Iron shortage 
affects mental development (a process which is reversible),32.4o,m,2S,,287,362.4,4.4" It 
also decreases immune responses, of which the implications may be small because 
a lot of pathogens do need iron toO.78,2'2.425 Moreover, therapeutically enhanced 
serum iron levels increase the number of infectious diseases,2" 
1-3. Transferrin. 
The major function of human transferrin (hTf) is the binding and transport of iron in 
the circulation. For the fetus it is the major, if not the only, source of iron.'2' Human 
transferrin is a serum B-globulin of 80 kD. Studies on its structure and function have 
been reviewed many times.··g• 5,'90 It is a monomeric glycoprotein with two domains 
(an N- and a C-site) both capable of binding one Fe'+ atom (affinity constant: 1 to 6 
x 1022 M-" for the N- and C-s~e respectively).'" Other metal ions like Zn2+, Cu2+ and 
AI'+ may be bound as well, for which, as for the binding of Fe'+, the concom~ant 
binding of an anion ((bi)carbonate) is required" The binding of iron is pH 
dependent. At pH 5-6 transferrin rapidly loses its iron, which is of major importance 
in the cellular uptake of iron (see further). 
The hTf gene is located on chromosome 3.437 It is mainly synthesized in the liver, 
Production of transferrin, however, has also been shown in adult brains, Sertoli cells 
and fetal muscles cells?4",.,,"6 mRNA for transferrin has been detected in placental 
homogenates suggesting the synthesis of hTf in the placenta.'" 
Transferrin blood concentration is 50-110 j/moljl which is increased by hormones, 
like estrogen, iron deficiency, and inflammation, for it is one of the acute-phase 
proteins.'46,m,2'7,268 About 24 hours after injection of turpentine hTf is increasingly 
synthesized.2",,.o,"2 Because the hTf-transferrin receptor interaction (see further) is 
affected by other acute phase proteins, a secundary effect cannot be ruled out.'" 
The transferrin plasma pool is thought to be replaced every 12 hours.197 
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Transferrin iron saturation is approximately 30 %. Under pathological conditions, 
however, this can raise up to 100 % (haemochromatosis). In a growing fetus the hTf 
iron saturation is approximately 60 %, indicating an 'uphill transport' of iron through 
the placenta. Iron saturation declines to adult levels in 6 months.261 Under these 
circumstances, four types of transferrin occur in the circulation: iron free 'apo-
transferrin', two types of monoferric transferrin 0ron bound to either one of the 
binding sites) and diferric transferrin. 
The binding of transferrin to its receptor is highly specffic but can be affected by 
ferritin in very high concentrations.3" Dfferric transferrin binds to the transferrin 
receptor with the highest affinity,17."'.43' presumably because of the conformational 
change induced by iron binding. ' " This accounts for the binding to placental TfRs 
as well. Compared to eachother, the two types of monoferric transferrins show no 
difference in affinity."'·161 Others could not detect any difference in affinity of apo, 
monoferric and dfferric transferrin for the TfR.51 This study was done on 
syncytiotrophoblast microvillous membranes, but its implications are unclear. 
The C-terminal domain of hTf is glycosylated.'63 Most frequently, four glycan 
branches are present, but from four up to eight branches can be found (Figure 1-
1).103.21' The terminal residue of these N-linked carbohydrate chains is sialic acid. 
From zero (asialo-transferrin) up to eight (octasialo-transferrin) sialic residues are 
found. Due to the number of branches and specially the number of sialic acids 
micro heterogeneity can be seen when the protein is studied by iso-electric 
focussing. lB' Special patterns seem to be related to specific diseases."8.190.191 
During pregnancy, the number of glycan branches on transferrin increases.34•19o 
This is in contrast with the glycosylation of the total pool of placental surface 
proteins. lO The relevance of this phenomenon is not yet understood, for, in 
guinea pig, it does not affect iron uptake by erythroid cells in the mother nor in the 
fetus." In humans and in the guinea pig, the affinity of transferrin for its receptor 
even decreases with an increasing number of glycans.90•238 It has been suggested 
that the increase in glycosylation of placental proteins may have a funtion in the 
inhibition of interactions between fetal trophoblasts and maternal leukocytes.lO 
A protein closely related to transferrin is lactoferrin, which also binds two iron 
atoms. Compared to transferrin the affinity of lactoferrin for iron is much higher and 
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Figure 1-1. Transferrin 
Schematic drawing of the structure of human transferrin. with its C- and N-terminal 
domains. Three examples of the micro heterogeneous forms of transferrin are 
shown. Most of the transferrin present is in the tetra-sialic form. (Drawing from: de 
Jong, van Dijk and van Eijk, 1990.'90) 
is not pH dependent. This results in an antimicrobial activity even if lactic acid has 
been released by microbial cells and/or stimulated leukocytes.'"o Lactoferrin does 
not seem to play any role in transplacental iron transport."·,,,·388 
Other iron binding serum proteins are haptoglobin and haemopexin. Haptoglobin 
binds free haemoglobin to enable the liver to take up and reuse the haem bound 
iron before it is lost into the urine. Serum haptoglobin concentration can be used as 
a standard of intravascular haemolysis. Free plasma haem is bound by 
haemopexin, also to prevent it from being secreted. Like haptoglobin!" 
haemopexin does not seem to play a role in the regular iron transport. 
Nevertheless, haemopexin receptors can be isolated from human placentae,''' and 
the expression of transferrin receptors is down-regulated by haemopexin.38' 
1-4. Ferritin. 
Ferritin is the major iron storage protein!" The protein is assembled of 24 
polypeptide subunits which form a symmetrical shell (Figure 1-2). In this shell iron is 
stored as a complex: (FeOOHls(FeO-OPO,H2)' Maximally 4500, but normally 2000-
2500 atoms of iron are stored. The storage of iron in ferritin is very efficient, and, it 
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seems likely that for that reason the 
protein is widely distributed in 
nature.9,389 
Two types of subunits exist: heavy (H) 
and light (l) with molar masses of 21 
and 19 kD respectively."'" Unclear is 
the report of a third, glycosylated, 'G'-
subunitJ6 
The combination of these ferritin 
subunits varies per organ, which 
causes microheterogeneity and 
Figure 1-2. Ferritin. 
The ferritin molecule consists of 24 
subunits which form a hollow shell. Iron 
enters the molecule via specific channels 
immunological differences. 'S3·267 H- in between these subunits. 
subunit-rich ferritins are found in the 
heart, HeLa-celis and the placenta, whereas liver and spleen ferritins consist 
predominantly of l-subunits. There may be functional differences between the H-
and l-subunits." l rich ferritins are more stable because of a salt bridge between 
amino acid lys" and Glu'07.''' The H rich ferritins usually have lower iron contents 
but can handle iron more rapidly."'" Nevertheless, l-subunits have a co-operative 
role in the uptake of iron.2" Waldo et al. (1991) showed that H-isoferritins take up 
iron more easily because of the formation of Fe(III)-tyrosinate ccmplexes . ." Wada 
et al. (1991) suggested that an appropriate spatial charge density across the cavity 
surface rather than specific amino acids are required for the uptake of iron by 
ferritin.410 
The differences between the subunits are reflected in their intended functions." l 
rich ferritins are thought to be long term storage proteins where H rich ferritins may 
have a function in cell-protection. '51 H rich ferritins also have a cytokine function 
inducing downregulation of cell proliferation. 52 In the light of these differences it is 
not surprising that H- and l-subunits are preferentially synthesized in response to 
different stimuli like inflammation and iron overload . .,·239.,13 
The majority of ferritin is located intracellularly.330 Approximately 30 % of the liver 
ferritin, however, is specially synthesized to be secreted into the circulation,254 but 
not all evidence for this hypothesis is conclusive.247 Ferritin blood concentrations are 
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67-533 pmoljl for males and 22-311 pmoljl for females (Dijkzigt, University Hospital 
Rotterdam). Its iron saturation is rather low (400-450 atoms of iron per ferritin 
molecule).434 Ferritin was also detected intra-articularly, and in seminal plasma.",225 
The cellular uptake of circulating ferritin might take place via receptors, for specific 
receptors have been detected on placental brush-border membranes, and T and B 
lymphoid cellsY79 
Ferritin synthesis is controlled at the level of translation (see further). It is digested in 
secondary Iysosomes and its half life is 31-58 h depending on sex and age.246 In 
iron overload it is 'degraded' to haemosiderin.31 ,318,320,426,435 
1-5. Transferrin receptor 
The first step in the delivery of iron to the cell is the binding of transferrin by the 
transferrin receptor (TfR).'08"S4 The TfR is a transmembrane glycoprotein composed 
of two identical disulfide bonded isomeres of 95 kD (Figure 1_3).'08,16',266,2'7,396,397 
Transferrin receptors can be detected on almost every cell but are mainly 
expressed by proliferating cells and cells requiring iron for specific purposes, like 
reticulocytes and syncytiotrophoblasts.125,128,248,409 There is one report of a second 
type of transferrin receptor on hepatocytes with a low affinity for hTf but non-
saturable." Remarkable is the fact that no TfRs are found on balicytotrophoblasts, 
the proliferating precursors of the syncytiotrophoblasts.168 
The number of surface TfRs are affected by cell-differentiation,,,,162,27' cell-
activation,'45 and a large group of different substances like iron, aluminium, 
haemopexin, and vitamin 0.35,266,381,382,386 
Transferrin receptors are located on the cell surface as well as intracellularly. This 
intracellular receptor-pool consists of TfRs being synthesized,"5 TfRs taking part in 
the endocytic cycle (see further) and possibly non-functional TfRs in storage-
pOOIS.417 Distribution of receptors among these pools can be infiuenced by, for 
instance, insulin, cell-differentiation, and anti-TfR antibodies. '06,3",427 
Non-membrane bound TfRs are present in serum.27,74,75,172 The plasma TfR is most 
likely a monomeric truncated form, lacking the cytoplasmic and transmembrane 
domains of the intact receptor. 347,387 Serum TfR concentration is a measure of 
erythropoiesis,27,m,215,3S5 and can be used as standard for tissue iron stores.7S,3SS,394 
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C-Slde C-Slde 
N-Slde N-Side 
Figure 1-3. Transferrin receptor. 
OLiOI SACCHARIDE 
(Co"'o'e~ ....,.,) 
OLIOI SACCHARIDE 
TRYl'SIN C~£AVAGE SITE 
PLASMA MEMBRANE 
PHOSPHOAILATION SITE 
The transferrin receptor consists of two identical polipeptide structures of 95 kD, 
both capable of binding one transferrin molecule. Oligo saccharides are present at 
the C-terminal domain, and at the N-terminal domain a phosphorilation site is 
present. (The drawing was adapted from Testa, Pelosi and Peschle)387 
It can also be used as an indicator of iron deficiency. '20,'72,353 Serum TfR 
concentration increases during pregnancy, especially in the third trimester.>8,217 
Finally, TfRs may playa role in the protection of syncytiotrophoblasts from maternal 
immune responses,'" 
1-6. Cellular iron uptake. 
In humans the major iron source of cells is transferrin. Small amounts of iron are 
delivered to the cell via ferritin, haemopexin and haptoglobin. The latter proteins, 
however, do not seem to have a structural role in cellular iron_supply.205,4" In vitro 
inorganic iron compounds can also deliver iron to cells.179.229,374 
The uptake of iron starts with the binding of transferrin by its receptorHO,183,'84 From 
there on two mechanisms are suggested for iron to enter the cell. Firstly, iron is 
released at the cell-surface and enters the cell via a 'membrane binder,,',,,275.404 
and, secondly, iron enters the cell via a process generally known as 'receptor 
mediated endocytosis'. 69,193,274,317 
During the first steps in this process the hTf-TfR complexes are clustered in clathrin 
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coated pits.,.7",. These pits function as molecular filters," For this highly efficient 
uptake, TfRs require specific structures in the cytoplasmatic taiL'" Second 
messengers do not seem to be functional. 3M Next, these clathrin coated pits are 
internalized by formation of endosomes,317 Of the surface TfRs, 10-15 % is 
internalized each minute.147,422 
Controversy exists over the necessity of occupation of the TfR for 
internalization.209,366,421 
Because different receptors with different destinations are endocytosed via the 
same endosome, sorting must take place intracellularly.29'"""" It has been shown 
that even TfRs follow different routes."2,'" 
Intracellularly, endosomes become acidic, a condition that is maintained by an ATP-
dependent proton pump.'24,"4,"7,337 At pH 5.0-6.5, Fe is released and subsequently 
transported to the cytoplasm by a process unknown so far. Nevertheless, we know 
that the TfR plays an important role in the intracellular release of iron, and minimizes 
nonspecific iron loss at the cell surface.2' 
The apotransferrin remaines tightly bound to the receptor and the entire complex is 
recycled back to the cell-surface." Due to the environmental pH of 7.4, hTf 
dissociates from the TfR leaving both ready to be reused. 
The TfR recycle time varies. Recycle times of 3 min have been found,17' 6 min,,,,2" 
14-20 min1O' up to 32 min"· depending on cell type and culture conditions. 1O' 
Receptor-mediated endocytosis is not specific for TfRs. For instance 
asialoglycoprotein, haemopexin and insulin receptors recycle as well'·'''''''·'''' 
In the cytoplasm iron is bound by ligands of a low molecular weight pool. Most 
likely this pool consists of a mixture of small iron chelating molecules.",1.,,1.2,42' It 
has been claimed that the low molecular weight pool does not participate in the 
cytoplasmic transport of iron."· Their results seem compatible with a steady state 
situation, which leaves open the possibility of a functional low molecular weight 
pool. 
Depending on the function of the cell, iron is transported via the low molecular 
weight pool to cellular organels, ferritin or - in polarized cells - to the 'opposite' 
side.296,343 
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1-7. Cellular iron homeostasis. 
Cellular iron uptake and storage should be regulated very carefully. Cells do need 
iron but a surplus of free iron could be dangerous. To solve this problem cells 
possess 'a highly specific regulation mechanism. 
Both the synthesis of TfRs (iron uptake) and ferritin Oron storage) are controlled at 
translational level via so called "Iron Responsive Elements (IRE's).'S5,156 IRE's are 28 
nucleotide stemloops in the 3' and 5' region of TfR and ferritin mRNA respectively 
(Figure 1-4);2" structures with a characteristic six-membered loop (CAGUGX).61 
These structures are also present on mRNA's of other proteins, not primarily 
involved in iron metabolism.71 ,203 
TfR mRNA contains multiple IRE's;" whereas only one IRE mediates the iron 
dependent control of ferritin mRNA The effectiveness of the latter IRE depends on 
the spacing between the 5' terminus of the ferritin mRNA and the IRE. 'as,l", 
An "Iron Responsive Element-Binding Protein" (IRE-BP) can bind to the IRE?3,32S,377 
This IRE-BP is also known as "Ferritin Repressor Protein" (FRP) and "Iron 
Regulating Factor" (IRF). The IRE-BP, identified as a ",90-kD protein, shows 
Transferrin Receptor mRNA Ferritin subunit mRNA 
IRE-BP IRE-BP 
® ® OJ mRNuII RI_.... /}1 
mRNA WJ cillo Ir-w,,-,,~-'" I 
/0 
WJ cAf2. I w"'.""~" I 
@ RI""_",,,, 
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g 
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Figure 1-4. The Iron-Responsive-Element hypothesis. 
In the left graph is depicted the effect of the IRE-BP on transferrin receptor mRNA 
translation. Without iron, also the affinity of the IRE-BP for the IREs, located at the 3' 
side, increases, which makes the mRNA less assessable for degradation enzymes 
(polygonal structure). 
The right graph shows the effect of the binding of the lron-Responsive-Element-
Binding Protein (IRE-BP) (filled circle) on ferritin subunit mRNA translation. In case 
the intracellular iron concentration is low, the affinity of the IRE-BP for the IRE 
located at the 5' side, increases and ribosomes are hampered to start mRNA 
translation. With iron, ribosomes can approach the ferritin subunit mRNA without 
difficulties. 
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similarities with aconitase, a protein of the citric acid cycle.140.199~10.327 This 
connection between iron uptake and energy production might contain a clue for the 
growth stimulating effects of iron. Aconitase mRNA is transcribed from a single gene 
on chromosome 9.327 By oxidation sufficient or high intracellular iron levels alter the 
conformation of the IRE_BP,1S7 which changes the Fe-S cluster of the protein.140.141 
This change reduces the affinity of the IRE-BP for the IRE followed by enhanced 
degradation of the IRE-BP. Also hemin is thought to have a specific effect on the 
IRE-BP via a specific binding site on the protein,m and causes Friend 
erythroleukemia cells to preferentially synthesize H-subunits.70 
Depending on the location of the IRE, dissociation of the IRE-BP has different 
effects. Ferr~in subunit mRNA, with its IRE's at the 5' side, becomes available for 
translation. TfR mRNA, w~h its IRE's at the 3' side, is degraded more rapidly!" By 
this mechanism high intracellular iron levels will lead to reduced TfR synthesis and 
elevated ferritin synthesis. The reduction in TfR numbers and the increase in ferritin 
will protect the cell from free iron.223 Iron shortage has the opposite effect.259 One of 
the consequences of this regulation mechanism is that the amount of cellular mRNA 
is not directly related to the amount of protein synthesized.239,325 
The control of iron homeostasis via IRE's is present in several cell-types, but has 
I 
not yet been demonstrated in syncytiotrophoblasts. In most of the studies on iron 
homeostasis, iron was supplied in inorganic compounds (like n~rilotriacetate iron or 
ferric ammonium citrate) in stead of a more physiological form (like transferrin). This 
is of special importance, because the cellular handling of iron, applied in different 
compounds varies.70,91,92,181 
1-8. Placenta characteristics. 
In mammals, fetuses are supplied with nutrients via the placenta. The morphology 
of the placenta differs per species and can be classified on basis of shape or the 
number of tissue layers separating the maternal and fetal circulation."',13,,204,'7,,365,412 
According to the latter classification four types of placentae occur: the 
epitheliochorial placenta (six (cell-)Iayers separate the maternal and fetal circulation; 
horse, pig, cattle), the syndesmochorial placenta (five (cell-)Iayers; sloth), the 
endothelial placenta (four (cell-)Iayers; some bats, cat, dog) and the haemochorial 
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placenta (three layers; man, rodents, rabbit, guinea pig, bat). The human placenta 
(placenta disco'idalis) has a tree-like structure (Figure 1-5). Villi are surrounded by 
maternal blood. The exchange area is enlarged via an increase in the number of villi 
during pregnancy,''' while microvilli on the apical cell-membrane of the syncytium 
further enlarge the surface area (up to 14 m2).230 
The human placenta is haemochorial, which implicates that in the mature placenta 
only three (cell-)Iayers separate the maternal and fetal circulations (Figure 1-5): the 
syncytium, formed by syncytiotrophoblasts, the fetal endothelial cells and in 
between the connective tissue. 
The syncytium, a structure with many nuclei and no intercellular membranes, is in 
direct contact with the maternal blood. It is formed by differentiation and fusion of 
The hemochorial placenta 
Figure 1-5. The haemochorial placenta. 
Schematic drawing of the tree like structure and the histology of the human 
haemochorial placenta. The figures represent 1: Umbilical cord, 2: Spiral artery, 3: 
Vein, 4: Intervillous space, 5: Syncytium formed by syncytiotrophoblasts, 6: 
Cytotrophoblast, 7: Fetal capillary with one erythrocyte. 
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the underlying cytotrophoblasts.107.ss1 Both syncytio- and cytotrophoblasts together 
represent approximately 13 % of the placental weight."7 
Desptte the close relationship between cytotrophoblasts and syncytiotrophoblasts, 
many differences exist between these cells. In contrast to syncytiotrophoblasts, 
cytotrophoblasts are proliferative throughout pregnancy.53.'51 It has been suggested 
that cytotrophoblasts undergo up to four amplification divisions before they fuse 
with the syncytium. '51 The cytotrophoblast-syncytiotrophoblast ratio does not 
change during pregnancy,'51 which could be explained in part by the loss of 
syncytiotrophoblasts into the maternal circulation.'" 
Syncytiotrophoblasts produce specific hormones: human chorion gonadotropin 
(hCG), human placental lactogen (hPL), progesterone, human pregnancy-specific 
B,-glycoprotein and schwangerschaftsproteins (Sp·S),"·97.119.166.207.291.419.420 whereas 
cytotrophoblasts produce hCG-releasing hormone and inhibin'01·'07·309 cAMP affects 
hormone production in general,292.30'.'21 .400 and hCG specifically stimulates the 
production of progesterone by syncytiotrophoblasts" 
For this thesis, one of the major differences is the expression of transferrin 
receptors (TfRs) by syncytiotrophoblasts.ss.".117.126.127.302 Though proliferative 
throughout pregnancy, both first and third trimester villous cytotrophoblasts lack 
TfRs.53•54.168 Only on the proximal portion of cytotrophoblast columns, an area of 
high proliferative activtty, TfRs were detected.53 In the mouse labyrinthine placenta, 
TfRs are expressed primarily on the differentiated trophoblast cells." In the normal 
human placenta, TfRs are located on the apical cell-membrane,117 which is indirectly 
suggested by the fact that transplacental iron transport is saturable from the 
maternal side.as 
Vanderpuye Kelly and Smtth showed the presence of TfRs in isolated basal 
membranes of the syncytial layer.403 The function of these receptors is puzzling. The 
transport of iron is clearly one-directional, from mother to fetus. Perfusion 
experiments wtth the guinea pig placenta showed an equally low retention in the 
placenta of albumin and diferric transferrin after bolus application at the fetal side, 
suggesting the absence of hTf TfR binding." There is some evidence for transferrin 
synthesis in the placenta.341 Maybe this hTf is involved in intracellular iron transfer. 
In that case basal TfRs might mediate iron transport across the basal membrane. 
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1-9. Placental transport. 
In all mammalian species the placenta exercises many functions, not in the least the 
transfer of nutrients and gases from mother to fetus. 
The transfer of nutrients can be mediated by specific membrane components like 
carriers and channels, but can also occur without specific membrane components. 
In the latter case transfer is purely diffusional, downhill a concentration gradient. In 
the former case transport can be both active as well as inactive.220 Examples of the 
non-mediated diffusional transfer are water, respiratory gases, urea, uric acid, 
hypoxanthine and in general small lipophilic metabolites. Transport mediated by 
carriers or channels is called passive (facilitated) if the driving force is a downhill 
electrochemical gradient, and active if it is directed against an electrochemical 
gradient. Examples of actively transferred metabolites using carriers or channels are 
Ca2+, Mg2+, Fe3+ and nearly all aminoacids.83,87,121,221,373 
When the diffusional capacity of the interface is the limiting factor for transplacental 
transport the transfer is called: diffusion (membrane) limited (uric acid, 
hypoxanthine). When a transport process is flow limited, it is the blood flow which is 
the limiting factor."2.113.269.338 Examples of the latter type of transport are water, 
ureum, and antipyrine. Active transport of nutrients is usually rapid, so that flux rates 
become flow dependent. 
Nutrients are transferred transcellularly (crossing the cellular membrane) or 
paracellularly. Evidence for paracellular transport has been obtained in the 
rabbit,372.373 and the guinea pig,'98.39' although continuity of these structures with 
both sides of the syncytiotrophopblast has not been prooved yet.198 These 
paracellular channels are believed to play a role in the transfer of small inert 
hydrophilic molecules.372 
Factors affecting placental transport processes are maternal and fetal blood flow 
rates, the size of the exchange area, the type of transport mechanism, diseases and 
toxic agents. In the third trimester placental transport capacity rises exponentially. 
This is most likely caused by the maturation of transport processes because the 
placental growth curve flattens earlier than the fetal."'·"8 Examples of diseases and 
toxic agents affecting placental transport functions are diabetes mellitus and 
cadmium.299,310,395,402 
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1-10. Placental iron transport. 
The mechanism of maternal-fetal iron transfer depends on the structure of the 
placenta (see Placenta characteristics).2'4,342 Mechanisms involved are phagocytosis 
of maternal erythrocytes in endotheliochorial placentae (sheep, some bats), 
absorption of iron by the yolk sac (rat and other rOdents), absorption of iron rich 
uterine secretions by accessory placerhal structures (pig) and absorption of 
maternal transferrin-bound iron in haemochorial placentae (human, guinea pig, 
rabbit).204 
Already in 1937 a relationship between pregnancy and serum iron concentration 
was assumed. '54 In man, the major, if not the only, source of iron for the fetus is 
maternal transferrin. '2' Also in rat, rabbit and guinea pig, Tf is involved,,,·as,37' There 
are reports on the existence of a ferritin receptor in the placenta as well,379 though 
this could be the TfR for this receptor also binds ferritin,17 The guinea-pig placenta 
takes up ferritin via a process compatible with receptor-mediated endocytosis.22' 
In human pregnancy, 250-300 mg of iron is transported,57 which is approximately 25 
% of the maternal iron stores.'" The majority of this transport takes place in the 
third trimester. '2' In rats iron is incorporated mainly in the fetal liver.102 In man, at 
term, transplacental iron transport is a fast process and, by that time, the placenta 
hardly stores any iron, '" 
The enormous amount of iron transferred to the fetus has its implications for the 
mother. '43 Maternal iron deficiency does not seem to affect the iron status of the 
fetus, although it increases the ratio of placental weight to fetal weight. ' " 
Furthermore, the lowest haemoglobin levels are associated with the highest 
birthweights and the largest placentae. 
In man there is clearly an optimal maternal hematocrit for pregnancy outcome.129 
Other parameters like serum ferritin and transferrin concentrations may be used as 
a standard of maternal iron status.so However, because of the day-to-day variation, 
at least 3 to 10 measurements are required to accurately determine these 
parameters.3,42 
The guinea pig placenta is autonomous in iron uptake; if fetuses are removed the 
placenta continous with the uptake of iron,'31,256.4'2 
In the guinea pig, rat, rabbit and human placenta, transplacental iron transport is a 
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one way active process."·43.234."""", .. " Transferrin iron saturation is higher in the 
fetal circulation.'S2 In rabbit, guinea pig and human maternal transferrin is 
endocytosed via receptor mediated endocytosis.17,72,88,'4 In man, iron dissociates 
from transferrin before it is transported to the fetus. 'OO After iron is released from 
transferrin into the cytOSOl, it is most likely bound by elements of the low-molecular 
weight fraction. Although arguments in favour of the presence of this iron-pool have 
been obtained in human, guinea pig and rat,72,as,256.432 its composition is still unclear. 
Many candidates have been mentioned, among which lactate."o Lactate is 
produced in large quantities by the endotheliochorial sheep placenta," but not by 
the haemochorial human placenta."4 Most likely, in human, lactate does not 
participate in transplacental iron transport, because it is mainly transferred from the 
fetus to the mother."" 
Brown et al. (1979) showed that human placental ferritin has tissue specific 
antigenicity, and most likely consists of several isoferritin populations. so These 
isoferritins differ in subunit composition.2" Five isoferritins have been separated by 
DEAE-Sephadex A-25 chromatography.2" Because of the tissue specific 
antigenicity, anti-placental ferritin antibodies can be obtained which could be helpful 
in the assessment of toxaemia of pregnancy.2'2 
Syncytiotrophoblast ferritin might play a specific role in transplacental iron 
transport.86 It is present in all layers of the trophoblast, especially near the 
surface.",SO,294 In the haemophagous badger placenta the maternal-fetal iron 
transport is even regulated via ferritin." 
The publications on the consequences of maternal iron status for fetal iron stores 
are contradictory. Sing la, Chand and Agarwal reported reduced fetal iron levels in 
infants of anaemic mothers. ,,2 Unfortunately, their publication does not explain in 
detail the procedure used to obtain umbilical blood samples, leaving open the 
possibility of contamination of cord blood with maternal blood. Others did not find 
any differences between infants born from anaemic or healthy mothers. '22.41' In rats, 
seriously iron-deficient mothers gave birth to iron deficient pUpS.231 Except for the 
nervonic acid to lignoceric acid ratio in the brain sphingomyelin, the effects were 
rapidly reversable by iron-supplementation. Experiments in rabbit and rat suggest 
the absence of an efficient short-term control mechanism for the reactions on both 
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induced iron overload as well as iron deficiency. ".258.272 (Lane, 1968) A long-term 
regulation mechanism could be present because alteration of maternal iron stores 
before mating did not change the transfer of iron to the fetus.272 
The infiuence of the fetus on placental iron transport is unknown. Fetectomy 
experiments in rats suggested the absence of a short-term regulation 
mechanism,,,·263 but similar to the effects of maternal iron supplies, long-term 
control is not excluded'7 
In human, transplacental iron transport control seems to guarantee sufficient iron 
supplies to the fetus. It has been suggested that maternal iron deficiency anaemia 
could increase the risk of preterm delivery."" On the other hand, specially preterm 
infants often have insufficient iron stores. 
Protection of the fetus from iron overload appears less well developed.24.".22'." •. '71 
Pathological processes affecting the placenta, like diabetes mellitus, may have their 
impact on the distribution of iron in the fetus.'" However, these results were 
obtained from neonates who died within 7 days postnatally. 
1-11. Fetal iron metabolism. 
Among others, the fetus requires considerable amounts of iron for cell growth and 
haem synthesis. Under normal conditions, and even if maternal iron stores are 
depleting, the fetus acquires adequate amounts of iron. In the fetal circulation iron is 
bound by fetal hTf with the same characteristics as adult hTf.40' Fetal hTf transports 
iron to the liver where it is stored in ferritin,'2' or used in erythropoiesis.'2 . ., 
In human pregnancy, fetal ferritin levels increase from 17.7 pg/I (18-20 weeks) to 
56.8 pg/I (32-35 weeks)." At term fetal serum hTf concentration is low. In 
combination with high hTf saturations, these parameters refiect sufficient iron stores. 
Postnatally serum ferritin levels increase, most likely because of the pause in 
erythropoiesis.'" 
The effects of marginal iron stores at birth (preterm infants) have been subject of 
investigation. Despite lower total body iron stores, compared to term neonates, 
preterm infants are at risk to develop iron overload shortly after birth. Not only do 
they often receive blood transfusions, but iron absorption is, regardless of the 
needs, proportional to the dietary iron contents as well.'" High blood iron levels are 
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associated with oxygen radical injury in preterm infants.376 and infections occur 
frequently if iron is artificially supplied."'''' Inside the uterus the child is loaded with 
iron, but shortly after birth it seemes to be protected from it. Due to rapid growth, 
haem synthesis, and inadequate iron uptake in the gut, iron stores could be 
depleted again in several months.',,·287.345.414 The influence of the fetal iron status on 
transplacental iron transport is unknown (see: Placental iron transport). 
In neonatal haemochromatosis fetal iron metabolism is disturbed. Livers of these 
patients are overloaded with iron, which might be present in organs not primarily 
involved in iron storage or erythropoiesis as well,'" but total body iron contents are 
not increased, suggesting that the primary pathogenesis is not an excess of 
transplacental iron transport. 
1-12. Scope of the thesis. 
For many years transplacental iron transport is subject of investigation. The results 
obtained strongly suggest that in the placenta some kind of transport regulation 
mechanism is present, but the location of this mechanism is obscure. We do know 
that transferrin receptors are expressed by syncytiotrophoblasts and that receptors 
densities are affected by iron. But, does this also mean that the amount of 
transported iron is influenced as well? 
In syncytiotrophoblasts ferritin is available in large quantities, but to what purpose? 
Does it only store iron for direct cellular needs? Does it prevent iron from being 
transferred to the fetus? And what is the role of IRE's in syncytiotrophoblasts, if they 
are present? 
These are the subjects this thesis will deal with. After a general introduction 
(Chapter I) and an explanation of the materials and methods generally used 
(Chapter II), the in vitro culture of cytotrophoblasts will be discussed (Chapter III). 
TfR-expression and its regulation are the subjects dealt with in Chapter IV. In 
Chapter V iron uptake will be described, followed by the role of ferritin (Chapter VI). 
Finally the place of the IRE's in the transplacental iron transport process will be 
discussed (Chapter VII). 
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Chapter II. MATERIALS AND METHODS. 
11-1. Chemicals. 
Calcium and magnesium free solution of Earle's Balanced Salts (EBSS), Fetal Calf 
Serum (FCS), Dulbecco's Modification of Eagle's Medium with 20 mM HEPES 
(DMEM-H), Medium-199 (M199), Hanks Balanced Salt Solution, translabelled 35S_ 
Methionin, penicillin, streptomycin and amphotericin were obtained from ICN 
Biomedicals, Zoetermeer, NI. Keratinocyte Growth Medium (KGM) was obtained 
from Clonetics USA, via Instruchemie Hilversum, NL. 2-[4-(2-Hydroxyethyl)-1 
piperazinylj-ethanesulfonacid (HEPES) and 1,4-Diazabicyclo[2,2,2joctan (DABCO) 
from Merck Nederland BV (Amsterdam, Nl). Ethylenediaminotetraacetate-disodium 
(EDTA) from Siegfried SA, Zofingen, CH. Modified Eagles Medium without l-
methionin and L-glutamin (MEM) from Gibco, Live Technology, UK. Gentamicin from 
Schering Corp., USA. Trypsin (1 :250 I.e.) and propidiumiodine from Sigma Chemical 
Company, St. Louis, USA. DNase grade II, dispase and collagenase from 
Boehringer Mannheim (D). Apo-transferrin from Behringwerke, Marburg, Germany. 
"FeCls and Na 12'1 from Radiochemical Centre Amersham, UK. lodo-Gen and Pierce 
Micro BCA Protein Assay Reagent from Pierce Europe BV, Oud Beijerland, NI. 
Percoll, Agarose EF, Sepharose 4B, Protein A-Sepharose CL4B were obtained from 
Pharmacia (Uppsala, S). Centricon-10 microconcentrators from Amicon (Grace BV, 
Rotterdam, NL). All chemicals were of the highest purity available. 
11-2. Monoclonal antibodies. 
Anti-desmoplakin 1/11 antibody was obtained from ICN-immunobiologicals 
(Zoetermeer, NL). Fluoresceine-isothiocyanate (FITC) labelled rabbit-anti mouse IgG 
from DAKO Corporation (Santa Barbara, USA). 
11-3. Trophoblast-cell isolation. 
Normal human placentae were obtained from the Department of Obstetrics, 
University Hospital Rotterdam/Dijkzigt, Rotterdam, within half an hour after 
spontaneous delivery. These placentae were processed according to either the 
procedure as described by Bierings et al. (Procedure A),36 or by a procedure based 
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on that of Karl et al. (Procedure B).'94.195 
In procedure A the cell-isolation technique of Hall et aI., (1977) and Kliman et al. 
(1986) was modffied by the addition of CaCI,.2H,O (1 mM) and MgS04 .7H,O (0.8 
mM) to the enzyme solution."·14'.'" 
Procedure B was performed as follows. A thin layer of endometrial tissue was 
discarded and a total of 60-70 gram villous tissue was cut out from the maternal 
side of the placenta. These villi were washed in 0.15 M NaCI (4'C), minced and 
exposed to an enzyme solution consisting of 100 ml Ca'+, Mg'+ free Hanks solution, 
2.5 U/ml dispase, 25 mM HEPES, pH 7.4 for 40 min at 37'C. Collagenase (12 mg) 
was added directly to the villi/enzyme solution mixture, followed by prolonged 
incubation for 15 min at 37'C. Digestion was stopped by the addition of 100 ml 
Ca'+, Mg'+ free Hanks solution supplemented with 25 mM HEPES and 2 mM EDTA. 
The obtained cell-suspension was serially filtered through wire mesh (pore size from 
1000 pm to 90 pm) and centrifuged (10 min, 750 g). The pellet was resuspended in 
approximately 4 ml Ca'+, Mg'+ free Hanks solution with 25 mM HEPES, and layered 
on top of Percoll gradient. This Percoll gradient was made from 70 % to 5 % Percoll 
(" Iv) in 5 % steps. Highly purffied cytotrophoblasts were obtained from the middle of 
the Percoll gradient (density, 1.048-1.062 g/ml).35.'12 The gradient was centrffuged 
for 20 min (900 g). The middle section, in between the erythrocytes (bottom) and 
the cell-debris (top), was roughly removed and washed with Ca'+, Mg'+ free Hanks 
solution containing 25 mM HEPES. DNase (approximately 10 mg) was added to the 
cell-suspension followed by incubation for 5-10 min at 37'C. Subsequently the cell-
suspension was layered on top of a second identical Percoll gradient and 
centrifuged for 20 min (900 g). Cytotrophoblasts were carefully removed by 
fractionation of the gradient. Finally the were washed twice with Ca'+, Mg'+ free 
Hanks solution, containing 25 mM HEPES. 
By these procedures a cell-population is isolated consisting of cytotrophoblasts for 
at least 95 %.'94.'" This has been reconfirmed in our laboratory by 
immunocytochemical staining with a panel of monoclonal antibodies (CD3, CD5, 
CD14, CD15, CD20, leucocyte common antigen CD45, and the trophoblast specific 
antigens ED 235 and ED 341 both from S.F. Contractor, London UK permitting 
positive as well as negative identification.35.73 Furthermore the percentage of hCG, 
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hPL and SP-1 producing cells was revealed by immunocytochemical staining.as.37 
Cells obtained were counted (using a BOrker counting-chamber) and, depending on 
the type of experiment either directly used or diluted to 6 x 10' cellsjml in culture 
medium. Of this cell-suspension 2.5 and 7.5 ml was plated out in 35 and 60 mm 
Falcon culture dishes, respectively (Greiner and S6hne, FRG). Except where 
otherwise specified culture medium consisted of 80 volume % M199 (Flow Labs); 20 
volume % FCS; 4 mM L-glutamine; 0.3 mgjml gentamicin; 50.0 IUjml penicillin; 50.0 
pgjml streptomycin and 2.50 pgjml amphotericin. Osmolality was 280-300 
mOsmoljkg, pH 7.4. The medium was sterilized by filtration on a 0.22 pm Millipore-
GS filter (Millipore SA Molsheim, F). Cell-cultures were incubated at 37°C in 
humidified 5 % C02 j95 % air. 
11-4. Cell-culture conditions. 
In general the cells were allowed to recover from the isolation procedure for 18-24 
hours. Subsequently, to remove non-adherent cells, the culture dishes were washed 
twice with M199. In a few experiments the cells were allowed to recover for only 21-2 
hours but otherwise identically handled. Cell culture was continued at 37°C in 
humidified 5 % C02 j95 % air in fresh, identical culture-medium or fresh medium 
supplemented with 1.25 pM human dfferric transferrin (hTf-(2Fe)), 10 pgjml ferric 
ammoniumcitrate (FAC) or 50 pM desferrioxamine (Of). 
11-5. Transferrin iodination. 
Offerric transferrin was obtained by full saturation of human apotransferrin, using 
iron-nitrilotriacetate (Fe-NTA) (ratio 1 mol Fe to 2 mol NTA) and a tenfold molar 
excess of bicarbonate as the synergistic anion (buffered in 0.1 M Tris-HCI, pH 8.2). 
The excess of Fe-NTA was removed on a PO-10 Sepadex column (Pharmacia, 
Uppsala, Sweden) and by extensive dialysis against Tris-HCI buffer (pH 8.2). 
Transferrin iron saturation was checked by measuring the E470jE280 ratio which 
was always close to 0.045, indicating full saturation. One mg diferric transferrin was 
incubated with 12'1 (0.5 mCi) for 20 min at room temperature in a glass vial coated 
with 100 pg lodo-Gen. Free 12'1 was separated from radiolabelled transferrin on a 
PO-10 Sephadex column, followed by extensive dialysis against PBS (pH 8.2). The 
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final specific activity of the diferric 12'1-labelled transferrin varied between 230 and 
535 x 10' CPM/mg protein. 
11-6. Saturation of transferrin with "Fe. 
To saturate transferrin with "Fe the same procedure was used as described for 
non-radioactive iron. "FeCI, was added to nitrilotriacetate (NT A) in a molar ratio of 
1 to 2. This solution was together with a tenfold molar excess of bicarbonate as the 
synergistic anion added to a solution of apo-transferrin Oron to transferrin molar 
ratio 1 to 2). The reaction was buffered in 0.1 M Tris-HCI (pH 8.2). After 20 min free 
NTA-iron was removed on a PD-10 Sepadex column and by extensive dialysis 
against Tris-HCI buffer (pH 8.2). Transferrin iron saturation was checked by 
measuring the E470/E280 ratio. 
11-7. Protein determination. 
A homogenous sample was obtained by sonication for 10 seconds on melting ice. 
Protein concentration in the samples containing distilled water was determined 
according to Bradford.4' 
The samples containing Triton X-100 were analysed according to LOwry et al.252 with 
the modification of Wang and Smith:" or, if protein concentrations were expected 
to be low « 0.050 pg/ml), with the Pierce Micro BCA Protein Assay Reagent. 
Bovine serum albumin was used as standard. 
11-8. DNA-determination. 
DNA-contents of the samples were determined using the Nuclesan-100 kit (Sanbio 
BV, The Netherlands). This test is based on mitramycin.173 
11-9. B-hCG determination. 
Culture medium B-hCG concentrations were measured using an ES-600 auto-
analyzer (Boehringer Mannheim, D). The medium was removed at indicated times, 
and replaced by identical culture medium. Prior to analysis the medium was 
centrifuged for 5 min at 1200 g. Supernatants were used for B-hCG determination. 
The origin of the hCG was determined by immuno-cytochemical staining (all 
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reagents from DAKO Corporation, Santa Barbara, USA)." 
11-10. Statistics. 
To estimate the significance of the results, the Student's t-test was used in 
experiments with only two groups. In experiments with more than two groups the 
Student-Newman-Keuls test was used. In this test the outcomes are corrected for 
multiple comparisons. The Chi-square test was used for the experiments on 
receptor distribution. 
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Chapter III. CYTOTROPHOBLAST DIFFERENTIATION IN CULTURE. 
111-1. INTRODUCTION. 
Several models can be used to investigate transplacental transport processes. For 
instance, for general studies on the transfer of nutrients across the placenta the in 
vitro perfusion of placentae.4'.".B8.222.27o.,36 Detailed studies at sub-cellular level are 
not possible with this model. 
A model highly su~able for detailed studies on the cellular processes involved in 
transplacental transport, is the in vitro culture of e~her malignant choriocarcinoma 
cell_lines,'64.'02 or nonmalignant trophoblast cells."o.147.211 The major disadvantage of 
this model is the loss of the tissue connections which might affect the processes 
studied. 
Both in vitro culture of malignant cell-lines and of non-malignant cells have their (dis· 
)advantages. BeWo, JEG-3 and JAR choriocarcinoma cell-lines, are very usefull in 
studies on a wide range of cellular processes; because of their proliferative 
behaviour, many experiments can be performed with large numbers of cells. 93 In 
studies on cellular mechanisms involved in transplacental iron transport, these cell 
lines are less suitable. Malignant cell-lines, as it happens, do need large amounts of 
iron for cellular growth and cell-division. Much of the iron taken up by the cell, is 
therefore used for these processes, rather than being transferred to the "fetal side". 
In this respect, nonmalignant cytotrophoblast cells, freshly isolated from 
nonpathological placentae, presumably approach the in vivo behaviour of the 
syncytium more closely. 
Nevertheless, also the in vitro culture of cytotrophoblasts is not the ideal research 
model, because, once isolated from term (human) placentae, cytotrophoblasts do 
not proliferate anymore. For every single experiment freshly isolated cells are 
required and since the preterm intrauterine conditions and the v~lity of the isolated 
cells differ, the outcomes of similar experiments vary appreciably. 
Still, in v~ro culture of cytotrophoblasts was chosen as study model. Although 
interexperimental outcomes vary, the results w~hin each experiment are highly 
comparable to each other. 
To isolate cytotrophoblasts from chorionic villi, several protocols exist.'42.194.2".2S0,438 
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The cytotrophoblasts used in the experiments described in this thesis were isolated 
from term human placentae using two different procedures based on those 
described by Kliman et aL and Karl et aL '94"" These isolation procedures differ in 
the type of enzymes used, though both have a final Percoll gradient centrifugation 
as decribed by Kliman et aL in commen.''' 
Numerous studies have contributed to our present knowledge on the closely related 
characteristics and behaviour of cultured cytotrophoblast.'",346,436 As mentioned 
above, cultured cytotrophoblasts do not proliferate though differentiate into 
syncytiotrophoblastlike structures.'''212"" In culture many cytotrophoblast 
characteristics are lost and syncytiotrophoblast specific proteins are expressed.'" 
To monitor cytotrophoblast differentiation, morphological and biochemical criteria 
are used. Morphological criteria are the aggregation and fusion of the 
cells,."21'"",,,s which are cell-density and hCG dependent.15,346 The moment of 
fusion can widely differ with time.''' Examples of the biochemical differentiation are 
the expression of specific membrane antigens,"'"'''' the production of 
syncytiotrophoblast specific hormones (hPL, hCG, SP_1),",207"",28S and the 
expression of glycoproteins, like the transferrin receptor.",94 The biochemical rather 
than the morphological criteria are sensitive to culture medium composition, and 
additives. Not surprisingly, many biochemical functions are affected by specific 
growth factors and hormones.",'77,'88 Cyclic AMP also plays an important but 
selective role in trophoblast cell_metabolism.35,'7,'19,29"",,370,400 Adenylate cyclase 
stimulators cause similar effects.''' The cAMP induced effects are DNA mediated.21 ' 
BeWo choriocarcinoma cells start to differentiate in reaction to treatment with cyclic 
AMP metabolism affectors.1O,,429 Although BeWo choriocarcinoma cells seem useful 
in experiments on cAMP related processes, their in vitro culture is at best an 
imperfect model of trophoblast specific gene expression, because germ cell specific 
genes are expressed as welL'14 
Biochemical and morphological differentiation do not necessarily parallel each 
other.36,., Even the criteria for biochemical differentiation do not always occur 
simultaneously. Cyclic AMP for instance, strongly enhances hCG production but 
does not change transferrin receptor expression.3' In the literature controversy 
exists about the value of the different criteria for biochemical differentiation. 
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Since in studies on cellular iron metabolism iron poor medium has to be used, and 
because in our experiments differentiated cytotrophoblasts are required, syncytium 
formation by cytotrophoblasts cultured under iron poor conditions (which induce 
biochemical differentiation was investigated.35 The results were compared with the 
effects of Kerotinocyte Growth Medium (KGM) in which both biochemical differentia-
tion and syncytium formation have been shown to occur.95 
111-2. MATERIALS AND METHODS. 
111-2.1. Cell isolation and culture conditions. 
Cells were isolated according to procedure A as described in Chapter II (see 
Trophoblast-cell isolation), and cultured in either a medium based on M199 or KGM. 
The composition of the M199 based medium is described in Chapter II (see 
Trophoblast-cell isolation). The medium based on KGM consisted of 90 % (v/v) 
Keratinocyte Growth Medium; 10 % (v/v) FCS; 0.3 mg/ml gentamycin; 50.0 IU/ml 
penicillin; 50.0 Ilg/ml streptomycin and 2.50 Ilg/ml amphotericin. Cell culture 
conditions and cell denstties were as described in Chapter II for the control series 
(see Cell-culture conditions), except that the cells were cultured on 15 mm round 
cover slips in 35 mm culture dishes. At each time that cells were immunolabelled, 
the culture medium in the remaining dishes was renewed. 
111-2.2. Protein and DNA determination. 
Dish protein and DNA concentrations were measured as described in chapter II. 
111-2.3. Immunolabelling. 
Desmosomes were visualized by double immunolabelling. After indicated culture 
periods the culture medium was removed. The cells were washed three times wtth 
phosphate buffered saline (PBS, pH 7.4) and fixed by incubation (30 min) wtth 
precooled methanol 4°C. After one wash (PBS) the cells were stored at 4°C in PBS 
containing 0.5 % (w / v) bovine serum albumin and 20 mM NaN, until all samples 
were available. 
The coverslips were transferred to 12 wells-plates and incubated, for 1 h at room 
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temperature, with an optimal concentration of anti-desmoplakin 1/11 in PBS. Then 
they were washed 5 times in PBS + 0.5 % (v Iv) Tween-20 and incubated, for 1 h at 
room temperature, in PBS with fluoresceine-isothiocyanate labelled rabbit anti 
mouse IgG antiserum (FITC-RAM, in an optimal concentration) and 1 :50 diluted 
human heat inactivated serum. After 5 washes with PBS + 0.5 % (v Iv) Tween-20, 
the cover slips were treated with propidiumiodine (5pg/ml in PBS) for 10 sand 
washed once with PBS + 0,5 % (v Iv) Tween-20. Finally the cover slips were placed 
up side down on a drop of a DABCO solution (100 mg DABCO in 1 ml of a 2/1 
mixture of Glycerol and PBS), on microscope slides. 
111-2.4. Scoring of syncytium formation. 
The microscope slides were randomly coded by one assistant and examined by 
another, using a Zeiss fluorescence microscope. The first 100 nuclei seen, were 
-ria 
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scored for their presence in 
single cells, cell aggregates 
and syncytia as shown in 
Figure 111-1. Syncytium 
formation was checked using 
a confocal microscope 
(Nikon, Optiphot; Silvius 
Laboratory, Leiden, NL). With 
this equipment and soft-ware 
support, cell 'slices' of 1 pm 
thick can be studied for the 
binding of FITC-RAM and 
propidiumiodine, and 
Figure 111-1. Syncytium 
formation. 
Schematic drawing of the 
various stages in syncytium 
formation of cytotrophoblasts 
in culture. (A: Single cells, B: 
Cell aggregate, C: 
Syncytium). 
internuclear membranes can be detected and checked on continuity. 
The number of nuclei per syncytium was scored in the first 30 syncytia seen and 
the average number was calculated. The average syncytium size was estimated by 
measuring the surface area size of the first 10 syncytia seen, using the Videoplan 
Image Processing System. 
111-3. RESULTS. 
111-3.1. Dish protein and DNA contents. 
Culture-dish protein content varied (from 50 up to 150 Jig per dish) between 
samples isolated from different placentae. The variation in protein concentration 
between samples prepared from cells isolated from one placenta was small and 
therefore acceptable (SO maximal 10 % of mean dish protein content; constant with 
time). 
Up to 72-90 h after isolation, protein concentration remained stable but then fell 
significantly (aT < 0.01). Dish protein contents were independent of culture medium 
supplementation with hTf-(2Fe) (Figure 111-2). 
DNA concentration also declined (from 2.0 to 1.5 Jig/dish) after 72 h of culture (aT 
< 0.05) indicating cell-loss. Nevertheless, DNA concentration was more stable than 
dish-protein content which is depicted in Table 111-1 showing protein/DNA-ratios. It 
can be concluded that cultured trophoblasts are viable for at least a period up to 
Culture Experiment Experiment Experiment 
Time 1 2 3 
Day Mean SD n Mean SD n Mean SD n 
1 23.2 2.6 10 30.7 0.5 5 29.6 1.1 6 
2 22.3 5.0 9 31. 9 2.7 9 30.2 4.0 6 
3 23.7 2.6 10 28.3 2.5 6 
4 22.3 1.9 13 
5 14.0 1.7 17 15.4 2.1 6 
6 15.0 1.9 10 
7 14.1 1.9 20 
Table 111-1. Mean Protein/DNA ratios. Influence of culture time and hTI-(2Fe). 
Reproduced are the mean protein/DNA ratios (±. SO, n) of three highly similar 
experiments. 
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Figure 111-2. Protein content of culture dishes. Influence of culture time and 
hTf-(2Fe). Shown are the results of one experiment. Although different in protein 
quantity, all experiments were highly similar for the trend of protein loss. Depicted 
are the mean protein contents (±. SO) calculated from five dishes per series except 
for the overall means which were calculated from ten dishes. 
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Figure 111-3. hCG production by cytoirophoblasts in culture. 
Cells were cultured in M199 based medium. At indicated times, the medium was 
removed, centrifuged and hCG concentrations were determined. Fresh identical 
medium was added to the culture dishes. Calculated were the hCG productions per 
hour, related to dish protein contents, during the period previous to the removal of 
the culture medium. 
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Figure 111-4. Syncytium formation in M199. 
Cells were cultured in M199 based medium as described in materials and methods. 
Shown are examples of cells at each differentiation stade during syncytium 
formation. (A: Single cell, 4 h culture; B: Cell aggregate, 20 h culture; C: Syncytium, 
50 h culture). The bar represents 10 jim. 
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Figure 111-5. Syncytium formation in KGM. 
Cells were cultured in KGM based medium as described in materials and methods. 
Shown are examples of. cells at each differentiation stade during syncytium 
f.ormation. (A: Single cell, 4 h culture; B: Cell aggregate, 37 h culture; C: Syncytium, 
48 h culture). The bar represents 10 fJm. 
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Figure 111-6. Rate of syncytium formation. 
Presented are the combined results of three experiments. Cells were cultured in 
M199 or KGM based medium as described in materials and methods. The first 100 
nuclei were scored for being present in single cells, cell aggregates and syncytia. 
Shown are the percentages of nuclei in each cell type as a function of culture time 
and culture medium (M199 versus KGM). 
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72-90 h. Nevertheless, cultures for up to 1S0 h are possible without appreciable loss 
of protein and DNA if the placentae are obtained within 15 min after parturition. 
111-3.2. hCG production 
As depicted in Figure 111-3, hCG production strongly increased after approximately 
40 h. Total hCG concentrations were comparable to previously presented 
data.'4.211.285 In the fusion experiments, no fluorescence was seen on cell 
membranes of cells incubated without antibodies, nor on cells incubated with either 
anti-Desmoplakin 1/11 or FITC-RAM anti-serum. 
111-3.3. Morphological differentiation 
Examples are given of the various stages of cytotrophoblast 
differentiation in the M-199 based medium (Figure 111-4) and the KGM based 
medium (Figure 111-5). 
The percentage of single cells, cell aggregates and syncytia in both media is 
depicted in Figure III-S. Cytotrophoblasts rapidly aggregated, though single cells 
were seen throughout culture. The majority of the aggregates developed into 
syncytia, finally leaving approximately 15 % of the nuclei in the aggregated form. 
Maximally SO-70 percent of the nuclei were found within syncytia. On this point no 
difference was seen between the two media. However, the final percentage of 
syncytial nuclei was reached already after 40 h in KGM versus 50 h in M199. 
There was a dotted pattern of desmosomes on all cells early in culture, throughout 
culture on the single cells and on the syncytia formed. Cell-aggregates showed a 
pavement-like pattern of desmosomes on the intercellular membranes next to the 
dotted pattern on the upper cellsurface (Figure 111-4, Figure 111-5). This raised the 
following question. Light, touching the cell membranes at a tangent, could falsely 
suggest that these membranes are intercellularly located. Therefore syncytia were 
checked for the presence of intercellular membranes using a confocal microscope. 
With time, the number of nuclei per syncytium slightly increased in cells cultured in 
M199. In KGM, this number increased less clearly (not significantly) (Table 111-2). 
The average syncytium size seemed larger in KGM but differed widely and therefore 
did not differ significantly (0.50 < P < 0.20) from the average syncytium size in the 
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M199 series (162 pm', SD: 70 in KGM; 132 pm', SD: 64 in M199; Students-t test). 
M199 KGM 
Culture time 
Mn SD Mn SD 
48 h 4.0 ± 0.1 3.2 ± 0.2 
50 h 6.0 ± 0.8 4.6 ± 0.7 
66 h 6.2 ± 0.8 4.9 ± 0.8 
Table 111-2. Number of nuclei per syncytium. 
Cells were isolated and cultured as described in 'Materials and Methods'. Presented 
are means (Mn) and standard deviations (SD) of the number of nuclei per 
syncytium calculated from 30 syncytia. 
111-4. DISCUSSION. 
Cultured cytotrophoblasts have been used to investigate many placental functions. 
In general, trophoblasts can be cultured for 72-90 hours wtthout significant loss of 
protein and DNA (Figure 111-2, Table 111-1). Mean dish protein contents varied wtth 
cell isolation but were comparable to those published by others.",288 In some 
experiments the culture period could be extended to approximately 8 days, though 
only if the placentae were obtained within 15 minutes after delivery. Because the 
protein-DNA ratio was stable during at least 72 hours (Table 111-1) both can be used 
as standard for cell number. The combined loss of protein and DNA, after 
approximately 90 hours, indicated cell loss. 
B-hCG production increased significantly in the first 3 days. The decrease in B-hCG 
production in the next few days was highly comparable to the B-hCG production 
pattern previously described.",211,28' 
Specially because cultured cytotrophoblasts differentiate into syncytiotrophoblast 
like structures the model is suitable for studies on the placental uptake of nutrients 
(see Chapter 1V)'4,395 This differentiation process has both biochemical and 
morphological characteristics, which however, do not always parallel each other. 
Even the biochemical aspects of differentiation do not always occur 
simultaneously.36,95 
To my knowledge there is only one publication presenting clear evidence of 
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syncytium formation by cultured cytotrophoblasts.95 The authors however, do not 
present detailed information on the number of fused cells nor on the rate of 
syncytium formation. Others presented data on nuclei distribution in 
cytotrophoblasts cultured in DMEM_H_G.211.212 Their data are very similar to the 
results presented in Figure 111-6, but the classification method used, was based on 
light microscope morphology and not on staining of membranes and nuclei. 
In this chapter are shown the effects of M199 and KGM on syncytium formation 
rates, syncytium size and the average number of nuclei per syncytium in cultured 
cytotrophoblasts. The major difference between M199 and KGM is the enrichment 
of the latter medium with Epidermal Growth Factor, Insulin, Hydrocortisone and a 
poorly defined bovine pituitary extract. Both media have shown to induce 
biochemical differentiation (see Chapter 1V).35.94.95 
Morphologically, only small differences in effects were seen between KGM and 
M199. The process of aggregation and syncytium formation occurred more rapidly 
in KGM (Figure 111-6), but the average number of nuclei per syncytium was higher in 
M199. No signrricant difference was seen between the average syncytium sizes. 
Pure subjectively the KGM syncytia seemed larger, but due to the variation in 
individual surface area sizes (from 62 to 287 pm2 in KGM versus 48 to 224 pm2 in 
M199), significance was not reached (0.50 < P < 0.20). 
In both media, occasionally, large syncytia were seen. The nuclei of these rounded 
structures (up to 75 per syncytium) were small and unicoloured suggesting a low 
level of transcription. 
Syncytium formation, expressed as percentage of nuclei per structure type, can 
easily be affected by the selective loss of one type of structure in a specific 
medium. This would imply loss of protein and DNA. In the first 72 hours of culture, 
however, neither protein nor DNA is significantly lost (see Figure 111-2, Table 111-1). 
No figures are presented on protein or DNA loss in KGM cultured 
cytotrophoblasts.95.2OO Assuming that no DNA was lost KGM cultured 
cytotrophoblasts, the results indicate no major difference between the 
morphological effects of the two media tested. 
Although scientifically irrelevant, the minor, statistically not significant, differences in 
syncytium formation rate, and the average number of syncytial nuclei, in the two 
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culture media tested, may be explained by the following mechanisms. In cu~ure, 
cytotrophoblasts migrate, in which transferrin receptors (TfRs) appear to play an 
important role.47 KGM is thought to slow down the increase in surface TfR 
number's.'oo This might affect the migration capacity, independent of the process of 
cell-differentiation.47 Subsequently, the reduced mobility could lead to a lower 
average number of nuclei per syncytium. The increase in cytoplasma volume of 
cells cultured in KGM could be caused by the supplemented epidermal growth 
factor.54.277 
Morphological differentiation of cultured cytotrophoblasts seems independent of the 
culture media tested in the current study. For studies on the biochemical 
differentiation and on placental nutrient uptake, as few culture medium additives as 
possible should be used. Each additive might have its specific (special) 
effects,"'·34'.424 not considering the effects of growth factor combinations or 
matrices.115.249,286 
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Chapter IV. TRANSFERRIN RECEPTOR NUMBERS, DISTRIBUTION AND 
SHEDDING, IN IN VITRO CULTURED HUMAN CYTOTROPHOBLASTS. 
IV-1. INTRODUCTION. 
The transport of iron across the placenta requires the binding and uptake of 
transferrin by the syncytiotrophoblast (see Chapter I, Transferrin receptor).'84 
Transferrin uptake is a receptor mediated process, in which the transferrin receptor 
(ffR) plays an outstanding role (see Chapter I, Cellular iron uptake). 
It is generally believed that the number of TfRs at the cell surface membrane reflects 
the iron need of the cell. Large numbers of TfRs are found in bone marrow on 
erythrocyte precursors (haem synthesis), on hepatocytes 0ron storage), and on 
syncytiotrophoblasts (maternal-fetal iron transport). In normal individuals, the vast 
majority of cellular TfRs are found in the bone marrow (80 %).236,251,349 
As a consequence of the endocytic cycle, TfRs are found at the cell-surface as well 
as intracellularly. The distribution of TfRs over the locations varies with cell-type and 
culture condition.94,106,125 
Next to these two metabolically active sub-populations the existence of another TfR-
pool has been proposed by Hirose-Kumagai and Akamatsu. '63 The TfRs in this pool 
are intracellularly located but do not participate in the endocytic cycle. The presence 
of TfRs at the basal membrane is controversial. Faulk and Galbraith could not 
detect any TfRs in the syncytiotrophoblast basal membrane,117 while Vanderpuye, 
Kelley and Smtth, using isolated basal membrane could,4" Also in fused BeWo 
choriocarcinoma cells, TfRs are detected on the basal side of the cells'2 
A soluble form of the transferrin receptor is present in the circulation,27,35' These 
receptors originate from normoblasts and reticulocytes, Enhanced erythropoiesis 
and circulatory reticulocyte numbers are followed by increased serum TfR 
concentrations.27 Reticulocytes shed TfRs in vesicles."·,,,·,,oo,301 This process 
requires sorting of membrane proteins."" 
In rats, TfR containing vesicles can be isolated from the plasma.' ''' TfRs are 
released from the vesicles through proteolytic cleavage by membrane-based 
protease'S, •• Virtually all (99 %) of the soluable receptors are in the form of a 
truncated extracellular domain .• S,347,34S 
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Serum TfR concentration is a measure of erythropoiesis. ".172215.355 Serum TfR is 
also a useful indicator of functional iron deficiencY,'20·172.353 but not of iron 
absorption.74 In combination with hematocrit, retic index and erythropoietin, serum 
TfR concentration can be used to detect multiple mechanisms of anaemia in the 
same patient. 29 
In healthy pregnant females, serum TfR levels are not elevated as compared with 
nonpregnant levels, and appear to parallel erythropoietic activity and iron 
status. ".SO,354 Some reports, hOwever, claim that serum TfR concentration increases 
during the third trimester of pregnancy.217 Unfortunately, no other iron ststus 
parameters were measured in this study, so iron deficiency may have been the 
major cause. A~hough during pregnancy the erythrocyte precursors seem to be the 
major source of serum TfRs," the rapidly growing placenta could also contribute 
significantly to this pool of soluble receptors.''' 
If the placenta releases TfRs into the circulation, the syncytium formed by 
syncytiotrophoblasts would most likely be the source. 
Regulation of cellular TfR numbers is also possible by the control of receptor 
synthesis and degradation, In several cell types, TfR synthesis is controlled by the 
intracellular iron concentration.280 Regulation takes place at the translational level by 
means of iron responsive elements (IREs) on the mRNA of the protein (see Chapter 
II, Cellular iron homeostasis, and Chapter VII), In trophoblasts regulation of TfR 
synthesis via a mechanism of iron controlled IREs, has not been identified yet. 
Down regulation of surface TfR numbers in reaction to transferrin supplementation 
of the culture medium,'s which has also been described in HeLa cells:'s does not 
contradict the presence of an IRE-involved regulation mechanism. 
That some kind of precisely balanced regulation mechanism for transplacental 
transport is present is very likely, because of the enormous increase in iron 
transport during pregnancy on one hand and, on the other hand, the potential 
danger of high levels of free intracellular iron. 
Another argument in favour of a regulation mechanism for transplacental iron 
transport is the observation that fetuses do not suffer from iron induced anaemia, 
even if the maternal iron stores are depleted.87,322,413,433 Based on in vitro studies, 
shOwing TfR expression to be dependent on cell differentiation as well as iron 
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supplementation of the culture medium Bierings et al. suggested that the iron 
transport may be regulated by the alteration of surface TfR numbers similar to the 
variation of surface TfRs by HeLa cells, K562 cells and human monocytes.,·3S·'04.416 
Surface TfR numbers could be regulated by changes in the synthesis/degradation 
ratio, by redistribution of TfRs among (functionally different) sub-pools, and by the 
number of transferrin receptors shed into the maternal circulation. These 
mechanisms may, at least in part, function simultaneously. 
Redistribution of TfRs has been confirmed in several cell-types and might be 
infiuenced by the number of TfRs located in intracellular pools.,,·,,·,,6.27,.417.430 
Evidence for receptor shedding by the placenta, as a mechanism of regulation, has 
been obtained for the tumor necrosis factor receptor.406 
In the experiments presented in this chapter, we investigated the effects of culture 
time (differentiation grade) and iron enrichment of the culture medium on TfR 
shedding, distribution and synthesis/degradation ratio. 
JV-2. MATERIALS AND METHODS. 
JV-2.1. Cell isolation and culture conditions. 
The cells were isolated according to procedure A, as described in Chapter II. 
Culture medium was enriched w~h supplements as indicated (hTf-(2Fe), FAC, 
desferrioxamine), and renewed every 24 h. In the experiments on TfR shedding the 
culture medium was renewed twice daily. 
IV-2.2. Measurement of transferrin receptor shedding. 
Sample preparation 
Two culture conditions were compared (control medium versus hTf-(2Fe) 
supplemented medium, 1.25 pM). In each series two dishes were marked. The 
medium, removed from these two dishes, was separately stored at -20'C until all 
samples were available for determination of TfR concentration. 
To measure total TfR numbers, every time the medium in the remaining dishes was 
replaced, cells of one dish were lysed in distilled water and harvested with a rubber 
'Policeman'. Lysis was checked using an inverted microscope (CK2, Olympus, 
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Japan). Cell-suspensions were collected in pre-weighed tubes. At the end of the 
culture period the cells of the marked dishes were collected. All cell-Iysates were 
stored at -20·C until further procedures were carried out. These media and cell-
Iysates were used for TfR determination as described below. 
Determination of medium TfR concentration 
The cell suspensions were centrifuged for 10 minutes at 10 000 g and the 
supernatants collected. TfR concentration was measured as described previously,29 
after 1:2 dilution with 0.15 M phosphate-buffered saline (PBS, pH 7.4) containing 0.5 
% bovine serum albumin and 0.05 % tween 20. Sonication of the sample in a buffer 
containing 2 % teric (polyoxyethylene 9-laurylester, Polidocanol, Sigma P9641) did 
not change the TfR concentration. The tubes with the samples were reweighted to 
ascertain the sample volume. An aliquot was mixed with an equal amount of 0.2 % 
Triton X-100 and homogenized by sonication for 10 s in melting ice. Another 250 "I 
aliquot was mixed with 750 "I of a buffer solution resulting in a final composition of 
10 mM phosphate buffer (pH 7.4), 0.15 M NaCI, 2 % teric, 1mM iodoacetic acid, 0.5 
mM phenylmethansulfonylfluorid and 20 U Iml aprotinin. The mixture was sonicated 
on melting ice for 30 s at high setting in a Polytron homogenizer (Kinematca, Littau, 
Switzerland) and assayed for soluble TfR the same day after 1:2 dilution with 
Tween-PBS containing 2 % teric. 
IV-2.3. 1251-transferrin binding essays. 
To minimize the interference of residual receptor bound transferrin, cells were pre-
incubated for 15 min (at 37 ·C in 5 % CO,/95 % air) in M199 without additives. 
Finally, they were rechilled to 4 ·C and washed twice with PBS. 
Scatchard analysis 
The cells, cultured in either control medium or hTf-(2Fe) enriched medium, were 
incubated for 1.5 h at 4·C with increasing concentrations of 1251-labelled diferric 
transferrin C"I-hTf-(2Fe)). Nonspecific binding was measured in similar samples by 
addition of a 100 times excess of unlabelled hTf-(2Fe). After incubation the cells 
were washed three times with PBS. Finally, cells were lysed bij adding 1 ml destilled 
water and collected with a rubber 'Policeman'. Surface bound radioactivity was 
measured with a Packard 500C autogamma spectrometer. The concentration 
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dependent binding was analysed as decribed by Scatchard.3:32 
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Figure IV-1. Scatchard analysis of concentration dependent hTf-(2Fe) binding 
to cultured cytotrophoblasts. 
Cytotrophoblastswere cu~ured in control medium (Ctrl, ) or hTf-(2Fe) (---
-) containing medium. The number of membrane bound transferrin-receptors is 
clearly decreased. There is no change in affinity of hTf-(2Fe) for its receptor in 
reaction to hTf-(2Fe) enrichment of the culture medium. 
Surface TfR numbers 
To measure the number of cell-surface TfRs, cells were incubated for 116 h at 4 °C 
(long enough to reach equilibrium) with a concentration of 125 nM 1251_hTf_(2Fe). A 
transferrin concentration of 10 times Ko would give a 90 percent saturation. 56 The 
concentration used in the current experiments, was 60 times Ko (Figure IV-1). Under 
these condttions full saturation was reached." Nonspecific binding was measured 
by addttion of a 100 times excess of unlabelled diferric transferrin and never 
exceeded 25 % of the total binding of 1251_hTf_(2Fe). Nonspecific binding amounting 
up to 25 % is rather high for ligand concentrations used in Scatchard analysis."2 
However, at the ligand concentrations used it is not extreme. The cells were then 
washed three times wtth ice-cold PBS to remove unbound 1251_hTf_(2Fe). Finally, 
cells were 
lysed by addition of distilled water and collected wtth a rubber 'Policeman'. Surface 
bound radioactivity was assessed using a Packard 500C autogamma spectrometer. 
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TfRs were calculated from the amount of specIfically bound 1251-hTf-(2Fe). 
Total TfR numbers 
Cultured cells were washed three times with ice-cold PBS and lysed in 0.5 ml 0.1 % 
Triton XC100. Lysis was checked using an inversion microscope (CK2, Olympus, 
Japan). The detergent 'Triton X-100' has been widely used in receptor binding 
studies and no effects have been reported on receptor-ligand interaction.163 Cell-
suspensions were collected in pre-weighed tubes and homogenised by sonication 
for 10 s in melting ice. Tubes were reweighed to ascertain the sample volume. Of 
the cell Iysates portions of 0.1 ml were taken for protein determination. Cell Iysates 
were incubated with 1251-hTf_(2Fe) (final and saturating concentration 125 nM) for 1 
h at room temperature. Ammonium-sulfate was added in a 1:1 volume ratio, 
resulting in a 30 % (NH4),S04 solution to precipitate the 1251-hTf-(2Fe)-TfR complex 
(see Figure IV_2).315 
Samples were filtered through 1.2 J1m glass microfiber filters (GF-C, Whatman).315 
Filters were rinsed four times with 30 % (NH4),S04' Radioactivity on the filters was 
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Figure IV-2. 12'I_hTf precipitation. 
In creasing amounts of fully saturated (NH4)2S04 were added to a solution of BSA 
(50 J1g/ml) and 1251_hTf (125 nM) resulting in a final saturation of 0 to 100 %. After 
incubation for 2 h at 4°C the samples were filtered through Whatman GF/C fi~ers. 
The filters were rinsed four times and counted for radioactivity. Presented are the 
percentages of precipitated 1251_hTf as a function of (NH4)2S04 saturation of the 
sample. 
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measured as described above. TfR number was calculated from the amount of 
specifically bound 12sl_hTf_(2Fe). This method was carefully checked for precipitation 
of unbound 12sl-hTf-(2Fe) « 0.5 %) (Figure IV-2). 
Transferrin receptors participating in the endocytic cycle. 
Cells were incubated for 1 h at 37°C in medium M199 supplemented with 250 nM 
12sl-hTf-(2Fe) and successively washed three times with 
PBS (pH 7.4) at 4°C. To remove surface bound hTf-(2Fe) acid/neutral washes were 
carried out at 4°C: cells were firstly incubated for 10 min with sodium-acetate buffer 
(PH 4.5) and secondly for 10 min with PBS (pH 7.4). This procedure was repeated 
twice. Finally, the cells were lysed in distilled water and collected with a rubber 
'Policeman'. Radioactivity in the cell Iysates and the combined acid/neutral washes 
was determined as described above. Nonspecific binding was determined by 
binding of 12sl-hTf-(2Fe) in the presence of a 100-times excess of unlabelled hTf-
(2Fe). The number of surface bound TfRs was derived from the acid/neutral wash 
labile 12sl-hTf-(2Fe). The number of intracellular TfRs was calculated from the 
amount of radioactivity resistent to the acid/neutral washes. 
1V-2.4. Protein and DNA determination. 
Determinations of sample protein and DNA concentrations were performed as 
described in Chapter II. 
IV-3. RESULTS. 
IV-3.1. On transferrin receptor shedding. 
Figure IV-3 shows the trends of the decrease in protein content of the culture 
dishes, obtained in 6 experiments on TfR shedding. Using the trends of protein 
content decrease, the virtual dish protein contents at 0 hand 100 h culture were 
calculated, and from these results the average protein loss per hour was calculated. 
There was no difference between the protein loss from cells cultured in iron poor 
medium or in hTf-(2Fe) containing medium. The average protein loss was 0.22 %/h 
(from 165 to 129 Jig/dish in 100 h). 
The calculated TfR loss was comparable to the average protein loss. The number of 
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Figure 1V-3, Trends of protein loss, 
Shown are the trends of protein loss in six experiments, 
There was no significant difference between the results obtained in the control 
series (Ctrl, ) and the diferrictransferrin series (hTf-(2Fe), ----), The 
average protein loss was 0.22 %/h, 
TfRs in the culture medium was related to the total number of TfRs in the cell-lysate 
at the beginning of the corresponding culture period, The hourly TfR losses were 
calculated per period, 
The number of TfRs released in the culture medium as percentage of the total 
number of cellular TfRs are shown in Figure IV-4, Sonication of the samples did not 
change TfR concentration indicating that no TfRs are externalized in vesicles, The 
cells in the control series contained 1.60 pmol TfRs per mg protein, in the hTf-(2Fe) 
series cells contained 1,35 pmoljmg protein, These receptor numbers are close to 
the results obtained in the 12'I-hTf-(2Fe) binding studies, The average percentage of 
TfRs lost was 0,26 % per h, showing no curve or tendency, No significant difference 
(Students-t test: 0.20 > P > 0,10) in TfR release was seen between cells cu~ured in 
iron poor medium or in hTf-(2Fe) enriched medium (Ctrl: 0,18 %/h, SD .±. 0,065 and 
hTf-(2Fe): 0,35 'Yo/h, SD .±. 0,174 respectivily), 
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Figure IV-4. Transferrin receptor losses. 
Shown are the losses of transferrin receptor (TfRs) in six experiments; three control 
series ( ) and three diferrictransferrin series (----). TlR losses per hour are 
expressed as percentage of the total number of cellular TfRs .±. 1 SD. The average 
percentage was 0.26 %Jh. The loss ofTfRs in the control series (Ctrl, 0.18 %Jh, SD 
0.065) did not differ significantly from the loss of TfRs in the diferric transferrin series 
(hTf-(2Fe), 0.35 %/h, SD 0.174). Students-ttest: 0.20 < P < 0.10. 
From the results shown in Figure IV-3 and IV-4, it was concluded that 
syncytiotrophoblasts do not shed TfRs. The increased protein loss in one 
experiment (Figure IV-3), could have masked the number of TfRs excreted by 
shedding. This, however, was not the case because also in the other experiments, 
with very little loss of protein, the number of TfRs lost did not exceed the dish 
protein decrease rate. Based on the equal loss of protein and TfRs it is concluded 
that syncytiotrophoblasts do not shed TfRs. 
IV-3.2. Transferrin receptor numbers. 
According to the results presented in Figure IV-1, the number of membrane bound 
transferrin-receptors is clearly decreased. There is no change in receptor affinity for 
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Figure IV-5. Surface transferrin receptors. Influence of culture time and hTf-
(2Fe). 
Figure IV-SA. After indicated culture periods, the control culture medium ( ) 
was replaced by medium containing hTf-(2Fe) (- -; 0.1 mg/ml; Series A to D). Bars 
represent one standard deviation. . 
Figure IV-5B. Culture concfrtions were similar to those described under Figure IV-SA 
(Control series: -,-,-; hTf-(2Fe) series: -, +, +). In 5 culture dishes the hTf-(2Fe) 
fortified medium was replaced by iron poor medium at 65 hours (-, +,- series). Bars 
represent two standard deviations. 
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hTf-(2Fe), in reaction to hTf-(2Fe) enrichment of the culture medium. 
The number of surface TfRs increased with time and was affected by iron to the 
medium, a process which was reversible (Figure IV-SA, Figure IV-58). Cells cultured 
in iron poor medium increased the number of surface TfRs to a significantly higher 
level (Figure IV-SA; aT < 0.05), compared with cells cultured in hTf-2Fe containing 
medium. Replacement of iron fortified medium by iron poor medium led to a 
number of surface TfRs highly comparable with that of cells permanently cu~ured in 
iron poor medium (Figure IV-5B). These TfR numbers were significantly higher (aT < 
0.01) than those in cells permanently cultured in iron poor medium. In the cells 
cultured for 21,2 h, surface TfRs were not detectable with the procedure used; 
nonspecific binding in these cells was always comparable to the total binding of 12'1_ 
hTf-(2Fe). 
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Figure 1V-6. Surface transferrin receptors. Influence of culture time and 
desferrioxamine. 
After indicated culture periods, the control culture medium ( ) was replaced by 
medium containingdesferrioxamine (- -; 50 pM). 8ars represent one standard 
deviation. 
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Figure IV-7. Surface transferrin receptors. Influence of ferricammoniumcitrate 
concentration. 
After 24 h culture in control medium, culture was continued in 
ferricammoniumcitrate (FAC) containing medium (concentrations as indicated). 
Surface TfR numbers were determined as described in materials and methods at 40 
h culture. 
As compared with iron poor medium, desferrioxamine enriched medium did not 
further increase surface TfR numbers (Figure IV-6). Therefore, it is likely that cellular 
iron levels are not decreased by desferrioxamine more than by iron poor M199. 
Compared with hTf-(2Fe), the effects of ferricammoniumcitrate (FAG) on surface TfR 
numbers are small (Figure IV-7). A dose-dependent effect is seen, but surface TfR 
numbers are only about 20 % lower than in the control series (0 pg/ml FAC). 
Total TfR numbers increased with time (Figure IV·8). This increase was more 
pronounced when cells were cultured in iron poor medium (aT < 0.02). Here again, 
no further effect of desferrioxamine was seen (Figure IV-9). In the cells cultured for 
2" h, very small numbers of TfRs were detectable (0.28 pmol, .±. 0.03) TfRs/mg 
protein). 
IV-3.3. Transferrin receptor distribution. 
Wrth time there was a redistribution of TfRs among the functionally different 
compartments in the trophoblast cell. Figure IV-10 presents the results obtained in 
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Figure IV-S. Total transferrin receptors. Influence of culture time and hTf-
(2Fe). 
The cells were cultured in iron poor medium (---) for 24 h. From 24 hours on 
culture was continued in either iron poor medium (---) or hTf-(2Fe) fortified medium 
(- -) (0.1 mgjml). At indicated culture times total TfRs were determined as 
described in materials and methods ("'I-transferrin binding essays). 
one of three studies. The data show that about 45 % of all TfRs actively participated 
in the endocytic cycle. The other part is stored and functionally inactive. This 
distribution was stable with time unless cells were cultured in iron poor medium. In 
this case the percentage of active TfRs increased to about 56, significantly higher 
than the 46 percent of the hTf-(2Fe)-cultured series (p < 0.02). After 24 h about 30 
% of the TfRs were located on the cell-surface. With time a significantly increasing 
part (up to 46 percent) of the active TfRs were found on the cell-membrane (p < 
0.05), which depended on hTf-(2Fe) enrichment of the cu~ure medium. Finally, the 
percentage of surface bound TfRs (of the total of TfRs) was significantly higher (p < 
0.05) when cells were cultured in iron poor medium. The resu~ indicate that this 
was mainly caused by an increase in the number of TfRs actively participating in the 
endocytic cycle. 
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Figure IV-g. Total transferrin receptors. Influence of culture time and 
desferrioxamine. 
The cells were cu~ured in iron poor medium (---) for 24 h. From 24 hours on 
cu~ure was continued in either iron poor medium (---) or desferrioxamine enriched 
medium (- -, 50 JIM). At indicated culture times total TfRs were determined as 
described in materials and methods ('25I-transferrin binding essays). 
IV-4. DISCUSSION. 
Placental transport of iron has to be balanced very accurately. The first step in this 
process is the uptake of iron by syncytiotrophoblasts, a process which is TfR 
mediated. TfR expression can be studied in vitro in differentiating cytotrophoblasts. 
It was shown previously that different iron compounds affect cell-surface TfR 
numbers.36,38 Therefore, some kind of regulation mechanism for cell-surface TfR 
numbers is likely to function in syncytiotrophoblasts. 
Theoretically, TfR densities may be controlled by the release of TfRs into the 
maternal circulation (shedding), by variations in the synthesis/degradation ratio, 
causing changes in total TfR amounts, and by TfR redistribution among functionally 
different pools. 
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Figure IV-10. Transferrin receptor distribu1ion. Influence of culture time and 
hTf-(2Fe). 
Shown are the results of one experiment. Cells were cultured in iron poor control 
medium. After 24 h, culture was continued up to 90 h, in either iron poor medium or 
human diferric transferrin (hTf-(2Fe)) supplemented medium (0.1 mgjml). The 
figures represent the percentage of TfRs in each sub·group. 
IV-4.1. On tranSferrin receptor shedding 
Serum TfRs may originate from every TfR expressing cell. Common sources of the 
majority of serum transferrin receptors are ery1hrocyte precursers and, during 
pregnancy, the placenta. Serum TfR levels decrease in the first trimester of 
gestation, but increase again in the third trimeste.,,·217 Most likely this occurs 
because of the enhanced ery1hropoiesis, but it may be caused in part by the rapid 
growth of the maternal fetal interphase. 
The exact source of plasma TfRs could easily be revealed if TfRs showed tissue 
specificity, or if fetal and maternal TfRs differed immunologically. Unfortunately, this 
is not the case. 
A useful model to study TfR shedding is the in vitro culture of cells.66•21• 
In human tumor cell-lines, TfRs are externalized at a rate of 56 to 194 fmoljhj10· 
cells, most likely via vesicles?'· This process strongly depends on temperature and 
transferrin availability.25~1. K562-ery1hroleukemic cells have the highest TfR shedding 
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rate."· Related to cultured cytotrophoblasts these cells have high TfR numbers 
(0.149 to 0.176 pmol (see above) and 1.8 pmol respectively per 10· cells," of which 
they shed approximately 10 % every hour (0.194 pmoljh/10· cells)."· Cultured 
cytotrophoblasts do not shed TfRs and therefore this is not a mechanism used to 
reduce cellular TfR numbers in these cells. 
Nevertheless, two remarks have to be made. Firstly, the celltype chosen could have 
been incorrect. The cells used in this study were isolated from term human 
placentae. It is possible that trophoblasts change (decrease) TfR shedding towards 
the end of gestation. As a matter of speculation, this might be one of the factors 
starting the delivery, for TfRs are thought to play a role in the immunological 
interactions of the syncytiotrophoblasts with the maternal immune system."· To 
overcome this celltype-problem, cytotrophoblasts should be isolated from pre-term 
placentae obtained from caesarean sections on maternal indication. 
Secondly, although not convincingly proved, the loss of trophoblast cells into the 
maternal bloodstream could also contribute to the number of circulating TfRs.311 
Simpson, Mayhem and Barnes suggested the possibility of a constant turn-over of 
syncytiotrophoblasts in a way comparable to the situation present in the intestinal 
cryptes.351 In vitro this type of cell loss is difficu~ to differentiate from cells detached 
because of decreased viability. 
1V-4.2. Transferrin receptor numbers and distribution 
The results with regard to the concentration dependent binding of '''I-hTf-(2Fe) 
showed that differentiating cytotrophoblasts reduce surface TfR numbers in reaction 
to hTf-(2Fe) supplementation of the culture medium (Figure IV-1). No change was 
seen in receptor affinity. Therefore, it is possible to calculate TfR numbers from 
experiments using only one (saturating) '''I-hTf-(2Fe) concentration. 
In our studies surface TfR numbers increased until day 4-5 comparable to the 
production of hCG (Figure 111-1 and Figure IV-Sa). After this period hCG production 
fell, suggesting a metabolic/biochemical change/'s whereas TfR-expression 
ccntinued to increase or at least stabilized. 
The rate of increase in surface TfRs was not influenced by the availability of iron 
(Figure IV-SA). Replacement of the standard culture medium by hTf-(2Fe) enriched 
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medium, transiently reduced surface TfR numbers. Soon, however, the normal rate 
of increase was resumed, a revesible process (Figure IV-5B). As compared with 
iron poor medium desferrioxamine containing medium did not change surface TfR 
numbers. This suggests that desferrioxamine does not affect cellular iron 
homeostasis differently from iron poor M199. FAG iron on the other hand does not 
affect surface TfR numbers to the same level as hTf-(2Fe), even though the actual 
amount of iron added to the culture medium in the FAG series was up to 40 times 
as high (Figure IV-7). Apparently this iron compound is handled differently from hTf 
bound iron. 
The rate of increase as well as the numbers of TfRs were highly comparable with 
those found by Kennedy, Douglas and King.'oo Their results suggest that syncytium 
formation is related to a (small) supression of surface TfR densities.95 This 
suppression could be explained by the decrease in cell-surface area in fused cells, 
for TfR numbers are independent of cell-fusion,35 and were related to cellular 
protein. The suggestion of Kennedy, Douglas and King that cytotrophoblasts 
cultured in Ham'sjWaymouth's medium remain undifferentiated, and at the same 
time express TfRs, is highly unlikely because cytotrophoblasts in vivo do not 
express TfRs."·1S8.2oo The results of Kennedy, Douglas and King are more logically 
explained by culture medium induced differences in biochemical differentiation, 
independent of the morphological differentiation.2°O 
Differences in morphological and biochemical differentiation have been shown in 
other in vitro models as well. If, for instance, in BeWo choriocarcinoma cells 
syncytium formation is induced by cAMP-analogons or cAMP-phosphorylase 
inhibitors, the actual number of surface TfRs is reduced. 1O' In cultured 
cytotrophoblasts, cAMP-analogons as such neither stimulate syncytium formation 
nor modulate surface TfR numbers, although hGG production is increased 5 to 10 
fold,2.36 which is comparable to the reaction of BeWo cells. 
Similar to the surface TfRs, total TfR numbers increased with time as depicted in 
Figure IV-8 and Figure IV-9, particularly if cells were cultured in iron poor or 
desferrioxamine containing medium. 
Based on the results with regard to total TfR numbers it was concluded that iron 
affects the TfR synthesis/degradation ratio. However, these results do not exclude 
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the possibility of TfR redistribution, a process which, as a result of cell 
differentiation, has been demonstrated before in choriocarcinoma and K562 erythro-
leucemic cells.'06,174,27' No changes, however, were found in TfR numbers or in TfR 
distribution during differentiation of HL-60 human leukemic cells,'09 and in different 
grades of macrophage activation, respectively.'4S 
lime and hTf-(2Fe) had different effects on the TfR synthesis/degradation ratio and 
receptor redistribution (Figure IV-10). Surface TfR numbers, expressed as 
percentage of the active TfR sub-population, increased significantly with time 
(p < 0.05) and were not influenced by the availability of iron. This might be an effect 
of cell differentiation. The final distribution is highly ccmparable to that in BeWo 
cells.'05,106 The size of the active TfR population, expressed as percentage of total 
TfRs, was constant when, similar to the in vivo s~uation, iron was available. Iron 
shortage caused TfRs to redistribute between the inactive and active receptor pool. 
Within the pool of active TfRs there was a shift of TfRs to the surface independent 
of iron availability and therefore most likely caused by a process of differentiation 
similar to that in BeWo choriocarcinoma cells.'06 Surface TfRs might be increased to 
a pre-fixed percentage of the active receptor pool which has previously been 
suggested,36 
The variation in surface TfRs number, due to iron availability, was independent of 
cell-differentiation and can be explained by the shift of TfRs between the inactive 
and active pool. If, within the active TfR sub population, the distribution of TfRs over 
cell-surface and interior remains stable, this shift will automatically lead to an incre-
ase in surface TfRs. 
Another parameter of importance in the regulation of iron uptake and transfer is the 
affinity constant 'K,: for the binding of hTf-(2Fe) to ~s receptor. No modification of 
the K. value was found in response to iron supplementation of the culture medium 
(Figure IV-1), nor in response to growth hormones or cAMP-analognes'6 This is in 
ccntrast to the data presented by Kennedy, Douglas and King;OO which suggest a 
twofold higher K. after induction of syncytium formation by keratinocyte growth 
medium (from 6 to 12 x 107 /M). In view of the average serum hTf concentration of 
80 pmoljl, this change can hardly be of any physiological relevance!' 
Trophoblasts could regulate iron uptake (and by this way transplacental iron-
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transport) by variation of surface TfR numbers via changes in total TfR amounts and 
via redistribution of TfRs among the receptor pools. This is in accordance with the 
in vivo situation of iron deficient mothers carrying fetuses with normal iron stores. 
Nevertheless, the results described above, do not prove that there is indeed a 
causal relationship between the number of surface TfRs and iron uptake (see 
Chapter V). 
When transplacental iron transport processes are studied in cultured 
cytotrophoblasts, it should be considered that the iron transport system matures 
simultaneously with a regulation mechanism for cellular iron homeostasis. 
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Chapter V. IRON UPTAKE AND TRANSFERRIN RECEPTOR KINETICS. 
V-1. INTRODUCTION. 
In man, the major iron source of the placenta is maternal transferrin (hTf).'2' As 
described in chapter one (Cellular iron uptake), the iron uptake process in the 
(human) haemochorial placenta is 'receptor mediated endocytosis', for which 
transferrin receptors are required. 
Briefly, receptor mediated endocytosis can be described as follows. HTf is bound 
by tts receptor and internalized in endosomes. Due to acidification of the 
endosome, iron is released from transferrin and transferred to the cytosol by a 
process unknown so far. The hTf-TfR complex is recycled back to the cell surface 
where, due to the environmental pH (7.4), the ligand dissociates from the receptor. 
Both are then ready to be reused. 
Prior to uptake, TfRs are clustered in coated ptts. Some receptors, like the 
asialoglycoprotein receptor, are internalized and recycled, independently of the 
TfR.68 Others are internalized in the same endosomes as TfRs and, therefore, 
intracellular sorting of the receptors has to take place. Even TfRs do not take one 
pathway.366 The process of transferrin receptor trafficking has recently been 
reviewed by Stoorvogel et al. 3'" 
Because of the characteristiCs of 'receptor mediated endocytosis', it is obvious that 
cellular iron uptake rates depend on hTf concentration, hTf iron saturation, cell 
surface TfR numbers, and on the TfR cyde time. 
TfR cycle times, more specific the internalization and externalization rates of the 
receptor, are used for regulation of cell surface TfR numbers,58,106,279,3S3 but 
reduction of cell surface TfR numbers can take place without changes in these rate 
contanta.209 
As discussed in chapter IV, cytotrophoblast TfR vary in number and location. 
Changes in surface TfR densities could be of value in the uptake of iron by these 
cells. It has even been suggested that the whole process of transplacental transport 
might be regulated by syncytiotrophoblast cell surface TfR densities.36 This 
hypothesis is attractive, because of tts similartty wtth the IRE-involved regulation of 
intracellular iron levels, by variation of TfR mRNA translation; a mechanism which 
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has been found in other cell types. 
It has been shown that the number of TfRs is not the only factor controlling the rate 
of iron uptake. In K562 erythroleukemic cells, a 50 % reduction of cell surface TfR 
numbers in reaction to 4B-phorbol 12-myristate 13-acetate, did not change the 
uptake of iron from transferrin.'" In Friend erythroleukemic cells, iron uptake and 
TfR numbers are not proportionally increased in reaction to dimethylsulfoxide 
treatment. '67 In chick embryo breast muscle also TfR recycling kinetics, and 
possibly TfR distribution, can also affect the uptake of iron. '61 
Therefore, the effects of cell-differentiation and hTf-(2Fe) enrichment of the culture 
medium on both transferrin mediated total iron uptake and iron uptake rates were 
investigated. 
V-2. MATERIALS AND METHODS 
Cell-isolation and cu~ure conditions were as described in chapter II. Cell-isolation 
procedure A was used. After the standard recovery period, cells were cultured in 35 
mm dishes, either in standard control medium or in hTf-(2Fe) (1.25 pM) containing 
medium. 
V-2.1. Iron uptake from diferric transferrin. 
Total transferrin mediated iron uptake was determined as follows. Cells, cultured for 
indicated times, were washed twice with icecold PBS and subsequently incubated 
with 1.25 pM hTf-259Fe in M199 at 37'C in 5 % CO,/95 % air. At indicated times the 
incubation medium was removed and the cells were washed twice with icecold PBS. 
The cells were lysed by addition of distilled water (checked under an inverted 
microscope), and collected with a rubber 'Policeman'. Intracellular 59Fe was 
determined using a Packard 500c autogamma spectrometer. 
V-2.2. Transferrin receptor kinetics. 
To investigate the effects of cell-differentiation on TfR endocytosis and exocytosis 
rates, the experiments described below were performed 18 hand 65 h after 
initiation of the cell-culture. The effects of iron availability were studied using hTf-
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(2Fe) (1.25 JIM), which was added to the culture medium after the first medium 
change at 18 h. 
Transferrin receptor endocytosis rates 
To measure TfR endocytosis rates, single cycle experiments were carried out as 
described by Ciechanover et al.B9 At indicated times, culture medium was removed 
and the cells were washed twice w~h icecold PBS (PH 7.4). Cells were incubated 
for 11;2 h at 4°C in DMEM-H ~h 0.250 JIM hTf-(259Fe). After removal of the 
radiolabeled ligand and three subsequent washes with PBS, the cells were 
incubated in prewarmed M199 supplemented w~h 6.25 JIM hTf-(2Fe) at 37°C, for up 
to 1 h. At indicated times, TfR internalization was stopped by quick removal of the 
medium and immediate chilling of the cells by PBS washes (pH 7.4) at O°C. Next 
acid/neutral washes were performed: the cells were exposed to a sodium acetate 
buffer (25 mM sodium acetate, 150 nM NaCI, 2mM CaCI2, pH 4.5) for 10 min at 
4°C, followed by incubation with PBS (pH 7.4) for 10 min at 4°C. These incubations 
were repeated twice, and the incubation media combined. Finally the cells were 
lysed in distilled water (checked under an inverted microscope) and collected w~h a 
rubber 'Policeman'. Radioactiv~ in the combined acid/neutral washes and in the 
cell-Iysates was determined separately, USing a Packard 500c autogamma 
spectrometer. Acid/neutral wash labile radioactiv~ was considered to originate 
from the cell-surface. Acid/neutral wash resistant radioactivity was assumed to be 
intracellularly located. 
Transferrin receptor exocytosis rates 
To measure TfR externalization rates, experiments were performed as originally 
described by Ciechanover et al.B9 At indicated times, culture medium was removed 
and the cells were washed twice w~h PBS (pH 7.4, 4°C). Next the cells were 
incubated for 11;2 h at 37°C, in prewarmed M199 supplemented with 250 nM 1251_ 
hTf-(2Fe). After removal of the radiolabeled ligand and three subsequent washes 
w~h PBS (pH 7.4, 4°C), the cells were incubated with acid (sodium acetate buffer, 
pH 4.5) and neutral (PBS, pH 7.4) washes as described above. Next the cells were 
incubated with prewarmed M199, supplemented with 6.25 JIM hTf-(2Fe) at 37°C, for 
up to 1 h. At indicated times, TfR externalization was stopped by quick removal of 
the medium and immediate chilling of the cells by PBS washes at O°C. Again, three 
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acid/neutral washes were performed. The incubation media were combined. Finally, 
the cells were lysed in distilled water (checked under an inverted microscope) and 
collected with a rubber 'Policeman'. Radioactivity in all samples (first acid/neutral 
washes, externalization media, second acid/neutral washes, and cell-Iysates) was 
determined separately using a Packard 500c autogamma spectrometer. 
Radioactivity in the different samples was interpreted as described above (TfR 
endocytosis rates'). Radioactivity in the second acid/neutral washes was 
considered to be externalized. 
Calculation of the intemalization and extemalization rate constants. 
Rate constants were calculated from the rate of internalization and externalization of 
"Fe and 1251, respectively, as described below. In the studies on TfR internalization 
"Fe is preferentially used because it remains in the cell after uptake. TfR 
externalization is most efficiently measured by using hTf bound 1251. 
In the internalization experiments a substantial amount (approximately 50 %) of the 
radioactivity bound at 4°C, was released within seconds into the incubation 
medium, upon warming to 37°C. Comparable amounts were released in TfR 
internalization experiments in proliferative (50 %) and fused (65 %) BeWo cells. ' °S 
Comparable data were (55 %) were found by v Dijk et al." Excluding this amount of 
lost "Fe, the percentages of radioactivity in the incubation medium, at the cell 
surface, and in the cell, were calculated. The radioactivity remaining at the cell 
surface and lost into the culture medium during the hour of incubation were both 
considered not to be internalized. Therefore, the final percentage of intracellular 
radioactivity was fIXed to 1 00 % and the previously internalized amounts were 
adapted. Because the TfR internalization rate is equivalent to the rate of acquisition 
of acid/neutral wash resistance of the "Fe upon warming of the cells to 37°C, 
these curves were used to obtain TfR internalization rates. 
V-2.3. Protein determination. 
Cu~ure dish protein content was determined using the method of Pierce assay (see 
Chapter II, Protein determination). 
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Figure V-1. Initial iron up-take. 
Iron uptake from hTf-(2 'Fe), in the first hour of incubation, was measured at 
indicated times, in cells cultured in either iron poor control medium, or in hTf-(2Fe) 
supplemented medium (1.25 pM). Neither cell differentiation nor culture conditions 
significantly affected initial iron uptake. 
V-3. RESULTS. 
To measure initial iron uptake, cytotrophoblast cells were incubated for 1 h with 
1.25 pM hTf-(259Fe) at indicated culture times (Figure V-1)_ In the incubation period 
iron uptake was independent of cell-differentiation and culture conditions (hTf-2(Fe) 
availability). This implicates that initial iron uptake rates are not affected by these 
parameters. 
Prolonged incubation with hTf-(259Fe) (Figure V-2) caused differences in 
accumulated iron amounts between cells cultured for 18 hand 65 h. In a period of 
6 h, relatively undifferentiated cells (18 h culture) accumulated 70 % more iron than 
differentiated cells did. The composition of the culture medium (hTf-(2Fe) availability) 
had no influence on iron accumulation during the 6 h incubation period in cells 
cultured for 65 h. Differences in amounts of accumulated iron in reaction to cell-
differentiation, without changes in initial iron uptake, indicate that some kind of iron 
release mechanism matures during cytotrophoblast differentiation i!1 culture. 
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Cells were cultured for 18 h in control medium. Culture was continued in either 
control medium or hTf-(2Fe) supplemented medium (1.25 pM). Iron accumulation 
was measured at indicated times as descibed in materials and methods. Initial iron 
uptake is not affected by cell-differentiation nor by culture conditions. More iron was 
accumulated in less differentiated cells, suggesting that some kind of iron release 
mechanism matures during culture. 
TfR internalization rates, determined at 18 hand 65 h culture time, differed with cell-
differentiation and iron (hTf-(2Fe)) enrichment of the culture medium. In each of the 
Figures V-3, V-4 and V-5 results are depicted of four combined experiments. The 
curves showed the characteristics of a first order process and could easily be fitted 
in a one exponential curve plot according to the equation In(1-BJBmoxl = kt (see 
Figure V-3). The internalization rate constants (k,ot) derived from these fitted curves 
were: O.18/min in cells cultured for 1B h, O.OB/min in cells cultured for up to 65 h in 
iron poor control medium, and O.12/min in cells cultured in hTf-(2Fe) enriched 
medium. 
From Figure V-3, V-4 and V-5 it can be concluded that, apart from the amount of 
"Fe rapidly lost upon warming of the culture medium, a small part of the remaining 
radioactivity is subsequently lost in the following hour. With vd Ende et al. we 
believe that the differences in the percentages of 59Fe finally lost during incubation 
are caused by the variation of the internalization rates. '06 Reduced TfR 
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internalization rates allow more hTf-(2S9Fe) to dissociate from the receptor. 
The rate of TfR externalization can be measured using 1251-labelled hTf-(2Fe). By 
saturation of the TfRs participating in the endocytic cycle with 1251-hTf-(2Fe) at 37°G, 
and subsequent removal of the surface bound 125I-hTf-(2Fe) at 4°G using sequential 
acid/neutral washes, TfR externalization rates are equal to the rate of decrease of 
intracellular 1251 upon warming to 37°G. 
The TfR externalization rates were calculated as follows. The amounts of 
radioactivity present in the media and the second acid neutral wash were added 
and corrected for variation in cell protein. These corrected data were transformed to 
a 100 % scale, taking the amount of radioactivity associated with the cells at time 
t=O as 100 %. Since no difference was found between the 20h and 65h control 
data, the corresponding data points were pooled. Figure V-6 gives the transformed 
and time averaged data points of three independent experiments. 
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Figure V-3. Transferrin receptor internalization rate at 18 h culture in control 
medium. 
Shown are the combined results of three independent experiments. Gells were 
isolated and cultured for 18 h as described in materials and methods. After 
incubation with hTf-2S9Fe at 4°G, cells were incubated in DMEM-H at 37°G for up to 
1 h. At indicated times, radioactivity present in the culture medium, at the cell-
surface, and intracellularly, was determined. Of each sample are plotted the 
radioactivity present in each sublocation as a percentage of total radioactivity. The 
internalization curve fits a one exponential model (k: 0.180/min, t.: 3.9 min). 
69 
o 
:l' 
c 
o 
o 
&: 
120r----------------------------------------, 
96 ~ 
1\IT 
72 ~ 
1 "~"'t ................... I··· 
T 
" ......... -o._"'.:.::..::..~.______ i 
A"" ----e-.-
M ~1' t 
:t + I T ~ 
46 
o 
o 13 26 39 52 65 
Incubation time (min) 
+ Medium o Surface .&. Intracell. 
Figure V-4. Transferrin receptor internalization rate at 65 h culture in control medium. 
Shown are the combined results of three independent experiments. Cells were isolated and cultured 
for up to 65 h, in iron poor control medium as described in materials and methods, but otherwise 
treated as described for Rgure V-3. The internalization curve fits a one exponential model (k: 
C.CSS/min, t,: 8.7 min). 
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Figure V-So Transferrinreceptor internalization rate at 6S h culture in hTf-(2Fe) enriched medium. 
Shown are the combined results of three independent experiments. Cells were allowed to recover for 
18 h in control medium. Culture was continued for up to 65 h in hTf*(2Fe) enriched medium (1.25 
pM), as described in materials and methods, but otherwise treated as described for Figure V-3. The 
internaliZation curve fits a one exponential model (k: O.121jrnin,~: 5.8 min). 
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Figure V-6. Transferrin receptor externalization rates. 
Shown are the combined results of three independent experiments. Cells were isolated and cultured 
as described in materials and methods. Shown are the 125I~hTf extemalizations in cells cultured in 
control medium (rate constants did not change during culture) and hTf~(2Fe) enriched medium. 
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Figure V-7. Transferrin receptor extemalization rate constants. 
Semi-Iogarithmical plot of the curves shown in Figure V-S after modification as described in 'Results'. 
Depicted are the modified curves and the original data after subtraction of the percentage of 
radioactivity which remained in the cell after incubation for 1 h at 37°C. Extemalization rates were k: 
O.19/min (I,: 3.6 min) and k: O.278/min (t,: 2.5 min) for Ihe control (--l and hTf-2Fe (- - -l series 
respectively. 
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The two curves were analysed by non-lineair regression, using the Marquardt 
algortthm (StatgraphicsR). Since 25 to 30 % of the radioactivtty remains associated 
wtth the trophoblasts even after 60 min excubation, and since this fraction tends to 
diminish only very slowly, we fitted the data to the function: Y(t);C1*exp(-k*t)+C2. 
C2 gives the constant part and C1 *exp(-k*t) represents the first order exocytotic 
part. k is the first order rate constant. Using the estimates of the coefficients C1 and 
k, the exocytotic part of the function y(t) can be calculated. In Figure V-7 the results 
of the calculated curves are semi-logarithmically plotted. 
As depicted in Figure V-6 and V-7, the TfRs in the Fe supplemented series were 
more rapidly externalized. In the 18 h cultured cells t •. ,,,, was 3.6 min. Prolonged 
culture in iron poor medium did not change externalization rate constants. At 65 h 
culture the t •.• ", in the hTf-(2Fe) series was: 2.5 min. The corresponding 
externalization rates constants were k,,,,: 0.19/min and k,,,,: 0.24/min in the control 
and in the hTf-(2Fe) series, respectively. 
II Culture time (h) II 18 65 I 65 II 
II II I II 
II hTf-(2Fe) suppl. II I II 
II culture medium II I + II 
II II I II 
II t%;, int (min) II 3.9 8.7 I 5.8 II 
II II I II 
II kint (min") II 0.18 0.08 I 0.12 II 
II II I II 
II t1 ...... (min) II 3.6 3.6 I 2.9 II 
II II I II 
II k1,,,, (min") II 0.19 0.19 I 0.24 II 
II II I II 
II II I II 
II TCYde (min) II 10.9 15.7 I 11.7 II 
Table V-1. Transferrin cycle times. 
Internalization and externalization rates were measured, as described in materials 
and methods, in cells cultured in control medium for 18 hand 65 h, and in cells 
cultured for 65 h in hTf-(2Fe) supplemented medium. Total cycle times were 
calculated using the binding and dissociation rates obtained by Ciechanover et al." 
rates (3.0 x 10' M"1Tlin' and 2.6 min, respectively)." 
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The consequences of these changes in internalization and externalization rate 
constants are summarized in Table V-1. TfR total recycle times (T "",) were 
calculated using the figures of Ciechanover et al. on hTf binding and dissociation 
rates (3.0 x 10' M·-min" and 2.6 min, respectively)." In cytotrophoblasts cultured for 
18 hand 65 h in iron poor control medium T"". times were 10.9 min and 15.7 min, 
respectively. In the iron enriched series T"", at 65 h culture time was 13.2 min. 
V-4. DISCUSSION 
Syncytiotrophoblasts take up iron from hTf by receptor mediated endocytosis.72.'4.,21 
Because this is the major mechanism of iron uptake, the rate of iron uptake 
depends on hTf concentration, hTf iron saturation, surface TfR densities, and TfR 
cycle times. 
In the experiments described in this chapter, hTf concentration and hTf iron 
saturation were constant during incubation of the cells two factors with potential 
influence on iron uptake thus remain: surface TfR densities and TfR cycle times. 
The effects of cell-differentiation and hTf-(2Fe) availability during cu~ure on TfR 
numbers and distribution are discussed in Chapter IV. During cell-differentiation 
surface TfR densities increase and iron poor culture medium leads to higher TfR 
numbers. These changes in TfR numbers could affect iron uptake rates and 
transplacental iron transport, as previously suggested by Bierings et a1.3• 
The resu~ on TfR accumulation (Figure V-1) do not support the hypothesis that 
iron uptake is solely regulated by surface TfR densities. Independent of surface TfR 
numbers, the initial iron uptake is 80-100 pmoljmg protein/h. These uptake rates 
are similar to those obtained in K562 erythroleukemic cells (39 pmoljh/10' cells) 
and BeWo choriocarcinoma cells (50-110 pmoljh/mg protein).'06·20' In BeWo cells 
iron uptake rates depend on culture conditions, with the highest uptake rates in 
cells forced to fuse by theophyline supplementation of the culture medium. 
Previously, comparable but slightly lower Fe uptake rates (25 pmoljmg protein) 
were obtained in cultured cytotrophoblasts.'4 This uptake rate could be explained 
by the lower hTf iron saturation C2:. 75 %) used by these authors. 
Iron accumulation during 6 h in relatively undifferentiated cells (Figure V-2) 
amounted to up to approximately 700 pmoljmg protein. This pattern of iron uptake 
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was almost linear and very similar to that found in cytotrophoblasts cultured for 48 h 
in a 1:1 mixture of Ham's and Waymouth's culture medium." In this medium 
cytotrophoblasts less rapidly differentiate, according to morphological criteria. 
Cells cultured for 65 h showed a decrease in Fe accumulation rates during 6 h 
incubation, irrespective of hTf-(2Fe) supplementation of the culture medium (Figure 
V-2). This observation suggests that some kind of Fe release mechanism matures 
during cytotrophoblast culture, which makes Fe release by a process of diffusion, 
as proposed by Douglas and King, unlikely." Nevertheless, the effects of medium 
replacement, observed by these authors, indicate that the mechanism of iron 
release is sensitive to environmental Fe concentrations. 
The other factor of influence on iron uptake by means of receptor mediated 
endocytosis is the TfR cycle time. In several cell types, changes in internalization 
and externalization rates allow the cell to change surface TfR densities.58.279.383 
These rates are also affected by growth factors like the epidermal growth factor and 
the platelet derived growth factor." In contrast to the changes in TfR internalization 
and externalization rates, which parallel theophylline forced fusion of BeWo 
choriocarcinoma cells,'06 the growth factor induced changes in rate constants 
occurred rapidly. 
The process of receptor -mediated endocytosis comprises a series of reactions, 
each with its specific rate constant. In combination, these reactions result in the 
total TfR cycle time, and can be summarized in the equation: 
where T ",de is the total TfR cycle time, kb;o,. is the rate constant for hTf binding to 
the transferrin receptor, L the ligand (hTf) concentration (1.25 pM), k'ot the rate 
constant for TfR internalization, kext the rate constant for TfR externalization, and 
k,;". the rate constant for apo-hTf dissociation from the receptor at the cell 
surface." 
The rate constants for hTf binding and dissociation were not determined in the in 
vitro model used in our experiments, but were previously obtained by Ciechanover 
et al. in a human hepatome cell line (HepG2) (kb;". = 3.0 x 10' M· -min·; kdl... = 
2.6/min)." Because Ciechanover et al." studied the binding of human transferrin to 
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human cells (and thus human TIRs), and because no structural differences are 
described lor the TIR, originating from different human cell types, we assume that 
these rate constants can be used in the cytotrophoblast model. 
The experiments on TfR internalization showed that the surface TIRs were 
internalized with the same rate constant, that was changed in reaction to cell-
differentiation and hTf-(2Fe) availability during culture. 
In contrast to TIR internalization, TIRs externalization only varied in reaction to iron 
supplementation 01 the culture medium. About 30 % 01 the radioactivity was not 
released within 1 h. Using the same procedure, vd Ende et al. showed a similar 
pool of radioactivity (27 %) not released from 8eWo cells. 1O• This percentage 01 
radioactively might represent the non-active receptor pool shown in chapter IV. 
II intracellularly TIRs are distributed among functionally different pools, sorting must 
take place. The present knowledge on this process has been reviewed by 
Stoorvogel et al. '.9 In many cell types TIRs have to be sorted from the degradative 
pathway, and since cu~ured cytotrophoblasts do not shed their TIRs (Chapter IV), 
some kind 01 degradation pathway has to exist in these cells too. One of the other 
routes might pass through the Golgi complex to enable the cell to resialylate the 
receptor.'·o II this route through the Golgi complex is taken by the TIRs, these 
receptors should not be included in the pool 01 TIRs participating in the endocytic 
cyle. 
It has been described that in HepG2 cells 30 % 01 the asialoglycoprotein receptor 
are not involved in the endocytic cycle, and are possibly localized in the trans Golgi 
reticulum. Remarkably however, in this cell type, no TIRs were detected in these 
structures. '.8 In the human placenta brush border membrane and in the guinea pig, 
no asialoglycoprotein receptors have been 10und.90·,,, 
Using the internalization and externalization rate constants and the rate constants 
lor hTf binding and dissociation obtained by Ciechanover et al.,"9 TfR cycle times 
can be calculated (Table V-1). Under the in vitro conditions used, total TIR cycle 
time was the longest in cells cultured in control medium for up to 65 h (15.7 min), 
the cells with the highest TIR densities (see Chapter IV). In cells cultured in hTI-
(2Fe) supplemented medium for 65 h - conditions which result in less higher surface 
TfR numbers (Chapter IV)- total TIR cycle time was 11.7 min. The relatively shortest 
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total cycle time was obtained in 18 h cu~ured cells (10.9 min), which also had the 
lowest surface TfRs densities (Chapter IV). These cycle times are very similar to the 
TfR cycle times in non-fused (21.2 min) and fused (14.6 min) BeWo cells,1O· and 
indicate that the changes in surface TfR densities are neutralized by variation of the 
total cycle times. This is in agreement w~h the results on in~ial iron uptake by 
cytotrophoblast in wro. 
It could be that intracellularly TfRs are sorted into a resialylation pathway and/or a 
degradative pathway,'·'·'·9 from which the 12'1 is released in a free form or bound to 
hTf-fragments. Resistance of the externalized 12'1 to precipitation ~h 10 % TCA has 
not been tested, so no further data are available on protein (fragment) association 
of the externalized 12'1. 
In conclusion: despite the differences in surface TfR dens~ies, induced by cell-
differentiation and hTf-(2Fe) availability during culture (Chapter IV), iron uptake rates 
are not affected by these variables. This can be explained by the variation in TfR 
cycle times induced by cell-differentiation and cu~ure conditions. Iron uptake by 
cultured differentiating cytotrophoblasts, and most likely alsothe iron uptake by the 
syncytiotrophoblasts in vivo, is stable and balanced by changes in surface TfR 
numbers in combination with variations in TfR cycle times. The changes in iron 
accumulation rates in reaction to cell-differentiation strongly suggest the presence of 
some kind of iron release mechanism in cytotrophoblasts. 
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Chapter VI. FERRITIN IN HUMAN CYTOTROPHOBLASTS. 
VI-1. INTRODUCTION. 
Iron plays important roles in, for instance, DNA synthesis in cells, and in the 
degradation pathways in lysosomes.'90 but iron is also potentially dangerous. A 
surplus of free iron could catalyze hydroxyl formation."4,," Therefore, the majority 
of intracellular iron is stored in ferritin where it can do no harm.282 
As described in Chapter I (Ferritin), ferritin is a protein consisting of twenty-four 
polypeptide subunits. Each molecule can store maximally 4500 iron-atoms but is 
normally saturated for 20-25 %.''' There are two types of subunits: heavy (H) and 
light (L)."',. Corresponding with a predominance of H- and L-subunits, there are H-
and L-isoferritins with functional differences. Compared to H-rich ferritins, L-rich 
ferritins are basic and more stable. They process iron less rapidly, but have higher 
iron contents.12,98,151 
Placental isoferritin composition changes during pregnancy to an approximately 
equal amount of acidic and basic isoferritins at term.50~18.235 
In cell culture, the form iron is offered in is important for the mechanism of iron-
uptake."·,,,181,,28 The implications of the iron compound for the intracellular handling 
and storage of iron, are unknown. Different effects are expected because 
nitrilotriacetate iron did not enhance cell proliferation in mouse lymphocytes.4• 
In vivo, the majority of iron is offered to the trophoblast bound to hTf.'21 
According to the IRE hypothesis, the storage of intracellular iron is efficiently 
regulated by the effects of iron on ferritin mRNA translation (see Chapter VII), as 
has been shown in cells only in control of their own iron stores. 
A different situation occurs in syncytiotrophoblasts, because these cells form the 
first layer of the maternal-fetal barrier. They have to keep intracellular free iron levels 
as low as possible but, on the other hand, the transplacental transport of iron 
should increase to very high levels, especially during the third trimester.87,322,413 
In this Chapter the effects are shown of diferric transferrin and ferric-
ammoniumcitrate on trophoblast ferritin concentration, ferritin iron saturation, and 
ferritin subunit ratio. 
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Ferritin synthesis and TfR synthesis are discussed in light of the I RE-hypothesis in 
Chapter VII. 
VI-2. MATERIALS AND METHODS. 
VI-2.1. Materials. 
The required chemicals and products are described in chapter II. Immun-Lite assay 
kits were obtained trom Bio-Rad, Richmond, USA. 
VI-2.2. Placental ferritin isolation. 
Placental ferritins were isolated according to Konijn et aI.218 Briefly: placenta tissue 
was washed twice in phosphate buffered saline and homogenized in distilled water 
containing 0.1 mM PMSF and 0.02 % NaN,. Insoluble material was removed and 
ferritin was isolated from the supernatant by addition of ammoniumsulphate (pH 5,2) 
until 50 % saturation was achieved. The precipitate was resuspended in 29 mM 
sodiumphosphate buffer (pH 7.0). Insoluble material was removed. After 
u~racentrifugation (120,000 g, 3.5 h) the pellet was chromatographed on a 
Sepharose 4 B column. Ferritin subtractions were obtained by ion-exchange 
chromatography on a DEAE-A25 column (0.154-0.64 M NaCI) and analysed by 
agarose iso-electric focussing (PH: 4-6) using the Pharmacia Phast system. Gel: 1 
% Agarose EF. Running conditions: prefocussing phase: 1000V, 2.0mA, 3.5W, 
15°C, 60Vh; application phase: 200V, 2.0mA, 3.5W, 15°C, 15Vh; separation phase: 
1000V, 5.0mA, 3.5W, 15°C, 60Vh. 
VI-2.3. Cytotrophoblast cell isolation. 
Cytotrophoblast cells were isolated using both procedure A and B (see Chapter II, 
trophoblast cell isolation). 
The cells obtained by procedure B were counted (using a BOrker counting-
chamber), and lysed by sonication in PBS containing 1 mM Phenyl-Methyl-Sulfon-
Fluoride (PMSF) and aprotinin (0.5 U Iml). The cell-Iysates were used for trophoblast 
ferritin subunit-ratio determination (see further). Cells obtained by procedure A were 
used for cell-culture. 
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VI-2.4. Cell-culture conditions. 
Isolated cells were counted (using a BOrker counting-chamber), diluted to 6 x 105 
cells/ml in culture medium, and plated out in 35 mm and 60 mm Falcon culture 
dishes (1.5 and 4.5 x 10' celiS/ dish respectively). Standard control culture medium 
was used (see Chapter II, Trophoblast cell isolation). 
Cells were allowed to recover from the isolation procedure for 24 h and, prior to the 
start of the experiments, washed twice with M 199 to remove non-adherent cells. 
Cu~ure was continued as descibed in Chapter II (Cell culture conditions) in control 
medium, or in medium supplemented with either hTf-(2Fe) (1.25 pM) or ferric-
ammoniumcitrate (FAC, 10 pg/ml). Culture media were refreshed every 24 h. 
VI-2.5. Trophoblast ferritin isolation. 
Preparation of trophoblast cell Iysates 
At indicated culture times, cells in 60 mm dishes were washed twice with PBS and 
lysed by addition of 1 ml distilled water (checked using an inverted microscope 
(CK" Olympus, Japan). The cells were harvested with a rubber 'Policeman' and the 
dishes were washed twice with 0.5 ml distilled water. Samples (in total 2 ml) were 
stored at -20°C until continuation of the procedure. Homogenous samples were 
obtained by sonication for 10 seconds in melting ice. Of each sample aliquots (50 
pi) were set apart for protein determination. 
Ferritin was isolated from the trophoblasts Iysates either by ultracentrifugation or by 
immunoprecipitation as described below. 
Ultracentrifugation procedure. 
The cell-Iysates were incubated with DNase (0.3 pg/ml) for 15 min at 37°C. 
Subsequently Proteinase-K (1 pg/80 pg protein) was added and again the samples 
were incubated for 15 min at 37°C.13 Next the samples were incubated for 5 min at 
75°C,13s rapidly cooled to room temperature and centrifuged for 10 min at 10,000 g 
(Rotor JA-21 Ti Beckman). The supernatants were transferred to clean, iron free 
tubes suitable for ultra-centrifugation (Rotor 70.1 Ti Beckman). The pellet was 
resuspended in 1 ml distilled water and again centrifuged for 10 min at 10,000 g. 
The supernatants were centrifuged for 20 min at 50,000 g. Finally the supernatants 
of the 50,000 g fraction were centrifuged for 4 h at 120,000 g (Rotor 70.1 Ti 
Beckman).306 The supernatants were removed and the pellets were resuspended in 
79 
20 pi LiOH-borate buffer (pH 8.6). Using this procedure, samples prepared from 
iron loaded cells contain, in addttion to ferritin, an iron binding compound. This 
compound does not react with anti-ferrttin antibodies but morphologically it 
resembles haemosiderin.319 It is most likely a ferritin degradation product. 
Ferritin-immunoprecipitation 
After sonication and heat-treatment (75°C, 5 min) the cell-Iysates were centrifuged 
(10,000 g, 15 min). Insoluble material was removed. The supernatants were 
concentrated to a volume of 0.5 ml using a Centricon-10 microconcentrator 
(Amicon). These samples were incubated for 18 h at 4°C with rabbtt anti-human-
placental-ferritin IgG bound to protein A-Sepharose CL-4B. Subsequently the 
samples were centrifuged (1100 g, 5 min). The precipitate was washed twice wtth 
distilled water and incubated for 2 h at 20°C with 0.05 M glycin-HCI (pH 2.7) to 
dissociate the ferritin-antiferritin complex.'" Rnally, the samples were centrifuged 
(1100 g, 5 min) to remove the anti-ferritin IgG protein-A sepharose complex. 
VI-2.6. Ferritin determination. 
Total ferritin concentration was determined using the Spectro Ferritin enzyme 
immunoassay (Ramco Laboratories). This ferritin elisa only determines 44 % of the 
placental ferrttins, which means that measured ferrttin concentrations should be 
multiplied by 2.27 to obtain the total ferritin concentration.37' Despite this 
disadvantage the Spectro Ferrttin kit was chosen, for it detects more of the 
placental ferritins then other immunoassays.49,375 
VI-2.7. Rabbit anti-human-placental-ferritin-lgG purification. 
A New Sealand NZW-rabbit was immunized with purified total human placental 
ferritin. IgG antibodies were isolated using an Econo-Pac serum IgG purification kit 
(Bio-Rad, Richmond, USA). 
VI-2.S. Iron determination. 
Total cellular iron contents were spectrophotometrically determined based on the 
method described by Harris,'49 using ferrozine as a chromogen. The method was 
slightly modified: the ferritin iron cores in 125 pi samples were dissolved by addition 
so 
of 62.5 pi 12 M Hel and 37.5 pi 40 % TeA. 
Ferritin iron contents were determined in immunoprecipitated ferritin, using a FAAS-
analyser PU-9200X and a eu-Fe-Zn lamp (Pye-Unieam, UK). Dry phase 110-130·e 
(30 to 40 s); ash phase 800·e (15 s); atomisation 2200·e (5 s). 
VI-2.9. Determination of trophoblast ferritin subunit ratios. 
Ferritin was extracted from freshly isolated cytotrophoblasts using the 
ultracentrifugation procedure, and its concentrations were determined using the 
Spectro ferritin immunoassay. 
Subunits of approximately 2 pg ferritin were separated by SDS-PAGE according to 
Schagger and v Jagow (1987) (10 % T and 3 % e).335 In this procedure tricine is 
used as trailing ion. 
The subunits were blotted on 0.2 micron nitrocellulose membranes (1 h, 100 V, 250 
rnA, at room temperature; Bio-Rad, Richmond, USA). The membranes were fixed by 
incubation with 0.2 glutaraldehyd in PBS (45 min),'04 followed by three washes in 
PBS (PH 7.4). 
Subunits were visualized with the Immun-lite assay, following the manufacterors 
instructions. Finally, subunit ratios were determined using the Ultroscan Xl 
Enhanced Laser Densitometer (lKB, Bromma). 
VI-2.10. Protein determination. 
Sample protein concentration was measured using the Micro BeA Protein Assay 
Reagent. 
VI-2.11. Statistics. 
The significance of the results was tested by using the Student-Newman-Keuls test. 
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Figure VI-1. DEAE-A25 chromatography of total placental ferritin. 
Ferritin was isolated and chromatographed as described in materials and methods. 
A 2 x 4O-cm column was used and 5 ml fractions were collected. Arrows indicate 
beginning of higher NaCI gradient. Four peaks were obtained, designated Basic I, 
Basic II, Intermediate, and Acid. 
VI-3. RESULTS. 
By chromography on a DEAE-A25 Column four ferritin subfractions were obtained, 
as depicted in Figure VI-1. The subfractions were designated 'Basic 1', 'Basic II', 
'Intermediate' and 'Acid', similar to Konijn et a1.218 A second 'acid' subtraction could 
not be obtained, neither by prolonged elution nor by higher NaCI molarities (up to 
1.0 M). 
Figure VI-2 shows a representative example of an agarose (1 %) iso-electric 
focussing of the placental ferritin subfractions obtained by DEAE-A25 
chromatography and depicted in Figure VI-1. Lane 1: markers, Lane 2: total 
placental ferritins and Lane 3-6: the four placental ferritin subfractions (3: Basic I, 4: 
Basic II, 5: Intermediate and 6: Acid). The observed iso-electric points were: total 
placental ferritin: pH 4.67-5.52, Basic I: pH 5.28-5.52, Basic II: pH 5.07-5.41, 
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Intermediate: pH 4.77-5.33 and Acid: pH 4.69-5.20. 
In Figure VI-3 the resu~s on trophoblast ferritin subunits are depicted, in relation to 
placental iso-ferritins. Although trophoblast ferritin subunit ratios varied with each 
placenta, the resu~s showed that trophoblast ferritin was further enriched with H-
subunits (L/H ratio: 1.86:1, SD 0.65, n = 3). 
Figure VI-4 shows the effect of iron enrichment of the culture medium on total 
cellular iron contents. Culture ·medium composition did not affect cell viability, nor 
cellular protein and DNA contents (results not shown). Addition of hTf-(2Fe) to the 
medium did not change intracellular iron amounts significantly (trom 6.0 to 6.3 
nmol/mg protein). The cells cultured in control medium lost a small amount of 
Figure VI-2. Iso-electric 
focussing of total placental 
ferritin and placental ferritin 
subfractions. 
Placental ferritin subfractions were 
obtained by DEAE-A25 
chromatography as described in 
materials and methods. (1) 
Markers, (2) Total placental 
ferritin, (3) Basic I subfraction, (4) 
Basic II subfraction, (5) 
Intermediate subtraction, (6) Acid 
subtraction. The iso-electric points 
were: total placental territin: pH 
4.67-5.52, Basic I: pH 5.28-5.52, 
Basic II: pH 5.07-5.41, 
Intermediate: pH 4.77-5.33, and 
Acid: pH 4.69-5.20. 
Figure VI-3. Total placental and 
trophoblast ferritin subunit 
composition. 
Trophoblast and placental ferritin 
were obtained as described in 
materials and methods. Ferritin 
subunits were obtained by SDS-
pH 
4.15_ 
4.55-
5.20-
H • 
L '-.' 
1 
123456 
2 3 4 5 
PAGE and Western blotting as described in materials and methods. The subunits 
were visualized using an Immune-Lite assay and by exposure of a photosensitive 
film to the blot. (1) Basic I subtraction, (2) Intermediate subfraction, (3) Acid 
subfraction, (4) Trophoblast ferritin, (5) Trophoblast ferritin, prolonged reduction. 
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Figure VI-4. Total cellular Fe-content. 
Shown are the combined results of four independent experiments. Trophoblast iron 
contents were determined as described in materials and methods. Compared to 
both the control and the hTf-(2Fe) series, cellular iron contents were increased 
significantly in the FAC series (aT < 0.002). 
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Figure VI-S. Cellular ferritin concentrations. 
Shown are the combined results of four independent experiments. Cells were 
isolated and cultured as described in materials and methods. Cellular ferr~in 
concentrations were determined using a Spectro ferr~in immunoassay. After 72 h 
culture, cellular ferr~in conCEntration in the FAC series becomes significantly 
different from both the control and the hTf-(2Fe) series (aT < O.OS). 
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Figure VI-6. Ferritin iron saturation. 
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Shown are the combined results of three independent experiments. Ferritin was 
immunoprecipitated from cell homogenates, as described in materials and methods. 
Iron saturation was measured using a FAAS-analyser PU·9200X (Pye-Unicam, UK). 
Compared to both the control and the hTf·(2Fe) series, ferritin iron saturation was 
increased significantly in the FAC series (aT < 0.01). 
iron (from 6.1 to 5.0 nmoljmg protein). However, cellular iron contents did not differ 
significantly from those in the hTf-(2Fe) series. In cells cultured in FAC enriched 
medium total iron amounts were increased (from 6.1 to 21.6-22.4 nmoljmg protein). 
These values are significantly different from those in both the control as well as in 
the hTf-(2Fe) series (aT < 0.002). 
Cellular ferritin concentrations (Figure VI-5) were similarly effected. Ferritin 
concentration slightly decreased both in the control and in the hTf-(2Fe) series 
(from 240 to 190 ng/mg protein). Cells cultured in FAC enriched medium increase 
ferritin concentrations to over 300 ng/mg protein, which becomes significant after 
72 h of culture (aT < 0.05). 
During culture, the amount of ferritin bound iron as percentage of total cellular iron 
slightly decreased from 23.6 percent to 20.9 and 18.9 percent in the hTf-(2Fe) and 
the FAC series, respectively (results not shown); these differences do not reach 
Significance. 
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Figure VI-6 shows trophoblast ferr~in iron saturation. Full saturation was set at 4500 
iron-atoms per ferr~in molecule. In the control and the hTf-(2Fe) series, ferritin iron 
saturation was 23 and 30 percent, respectively. In both series saturation was stable 
w~h time. Ferritin iron saturation in the FAC series significantly increased with 75 % 
(aT < 0.01). 
VI-4. DISCUSSION. 
The major function of intracellular ferritin is the storage of iron, which, in its free 
form, could become dangerous. 
Ferritin subunit composition causes heterogeneity. Mid-gestational human placental 
ferritin mainly contains acidic subfractions.23' Contradictory results on placental 
ferritin subunit compos~ion at term have been published. According to Brown et al. 
term placental ferritin is L-subun~-rich. 50 Konijn et al. published data showing a one-
to-one ratio of basic and acidic iso-ferritins."8 
Although we could not produce a fifth fraction designated "Acid 11","8 our 
preparation of total placental ferr~in closely resembled the placental ferr~in 
characteristics by these scientists. The shoulder in peak 4 might contain this fifth 
fraction (Figure VI-1). The isoelectric points of the ferritin subfractions, however, are 
highly comparable, indicating that similar products were obtained (Figure VI-2). 
Placenta ferritin L-H subunit-ratios varied slightly with each placenta. Remarkably, it 
differed from the L-H subunit-ratio of trophoblast ferritin (Figure IV-3). Most likely 
total placental ferr~ins are a mixture of ferrftins from different cell-types with 
variations in subunit-ratios. Trophoblast ferrftins are H-subunit rich (Figure VI-3). 
Since H-ferrftins handle intracellular iron more rapidly,'2.4
" 
this would fit in wfth the 
iron-transport function of the cells. 
The results presented in this chapter show that cells cultured in hTf-(2Fe) 
supplemented medium had a stable iron content, slightly higher than the cellular 
iron concentration in the control series (Figure VI-4). Because trophoblasts take up 
iron (Chapter V), this could be explained by iron release from the cells, without iron 
storage above the direct cellular needs; a mechanism consistent with the function of 
term syncytiotrophoblasts. 
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Cells cultured in FAC enriched medium accumulated iron. Apparently, iron bound to 
ammoniumcitrate is not processed (uptake/storage/transfer) similar to hTf bound 
iron. A difference in cellular iron processing, caused by the way iron is chelated, 
has previously been described.'" On the other hand, when in the FAC series iron 
uptake continues, it also leaves the cell, because a steady state situation is 
presumably reached within 24 h (Figure VI-4). 
High intracellular iron contents are cytotoxic, unless stored in ferritin. A surplus of 
iron above the ferritin storage capacity and the need for ferritin synthesis above the 
cellular capicities eventually lead to uncomplete degradation of ferritin into 
haemosiderin. Although less efficien~y, compared with iron stored in ferritin iron in 
this form is not as dangerous as iron in a free form. Also in trophoblasts a reaction 
to the intracellular iron concentrations was seen (Figure VI-5 and Figure VI-6). Cells 
confronted with high intracellular iron concentrations and high ferritin iron 
saturations (FAC series), increased their cellular ferritin. Because cellular ferritin 
levels are not increased in the hTf-(2Fe) series, and iron is taken up by these cells 
(Figure V-1 and V-2), the effect of FAC on cellular ferritin contents may be induced 
by a mechanism of self-protection, triggered by the increased intracellular (free) iron 
levels. 
In the hTf-(2Fe) series, cells were able to balance iron uptake and release. 
Intracellular iron levels did not change and no adaptation of cellular ferritin levels 
was necessary. Apparently, no extra ferritin is required for the transcellular 
transport of iron. 
Syncytiotrophoblasts are cells specialized in the rapid transport of many kinds of 
nutrients. Under physiological circumstances term syncytiotrophoblasts do not store 
iron (anymore).'" Therefore, when (physiologically) bound to transferrin, iron is 
taken up, possibly temporarily stored, and transferred through the cell, without loss 
of control. Only a small amount of iron is required for intracellular processes, which 
could easily be 'taken' from the iron-pool transported to the fetus. In such a cell 
type the control of iron uptake and storage do not necessarily have to be coupled. 
If the uptake of iron is regulated and the intracellular iron amounts are balanced by 
the release of iron, ferritin synthesis does not have to be regulated simultaneously. 
If iron is forced into the cell via an unnatural way (unphysiological iron chelators are 
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most likely taken up by pinocytosis,7o,92,181 ~ may be impossible for the cell to 
process the iron via the normal routes. Iron-release may be hampered and, 
subsequently, intracellular iron concentrations may become to high. Under these 
cond~ions of obstructed iron handling the cell can protect ~self by ferritin synthesis. 
In conclusion: the reaction of cytotrophoblasts cultured in v~ro on iron, with respect 
to the intracellular ferr~in levels, depends on the way the iron is chelated. The 
unphysiological iron chelator FAC increases ferritin synthesis, while hTf bound iron 
does not. Apparently, the iron-form is important for the intracellular route iron is 
processed in. 
Although there are discrepancies between the results described above and the 
regulation of ferr~in synthesis as proposed in the IRE-hypothesis (see chapter I, 
Cellular iron homeostasis) conclusions on the presence of an IRE-controlled 
mechanism of cellular iron homeostasis in syncytiotrophoblasts, cannot yet be 
drawn, Experiments on the effects of iron on transferrin receptor and ferr~in 
synthesis are required to reach such conclusions (see Chapter VII). 
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Chapter VII. THE SYNTHESIS AND DEGRADATION OF TRANSFERRIN 
RECEPTORS AND FERRITIN. 
VII-1. INTRODUCTION. 
Cellular protein concentrations can be controlled at many levels. Two of these levels 
are mRNA translation and the rate of protein degradation."'o 
In contrast to the mechanisms of degradation, many aspects of the translational 
regulation of TfRs and ferritin have been elucidated during the last decade. Growth 
factors and different iron compounds have been shown to affect mRNA 
translation,"'·2".26o Major functions in this regulation mechanism are performed by 
the iron responsive element (IRE) and the IRE·binding protein. The IRE is a 
stem loop of about 28 nucleotides present in the mRNA of TfR and ferritin.'4.280 
Similar structures have been found in, for instance, transforming growth factor 
mRNA and in 5·aminolevulinate synthase mRNA '33.203 The stemloop configuration is 
essential for the function of the IRE; mRNA that could not form a stemloop, bound 
1000·fold less well to the IRE-binding protein." The structure of the loop, especially 
of the top, is similar in TfR and ferritin mRNA The top consists of CAGUGX and an 
unpaired C is always present in the stem."·"5 
A cytosolic protein binds specifically to the IRE.23 This protein has been named iron 
regulating factor (IRF), ferritin repressor protein (FRP), and IRE-binding protein (IRE-
BP). The latter name will be used in this thesis. The IRE-BP has been isolated and 
purified, and eDNA encoding for the protein has been cloned.32'.327 
The IRE-BP is identified as an approximately 90-kD protein, and it shows many 
similarities with aconitase, an enzyme of the citric acid cycle."·'40.'99~10.327 The IRE-
BP has aconitase activity and aconitase binds to the IRE.192,44' 
Because of the similarities, it has been proposed that cellular energy production is 
coupled to cellular iron homeostasis." This connection between iron uptake and 
energy production might contain a clue for the growth stimulating effects of iron. 
Regulation of TfR and ferritin synthesis takes place by binding of the IRE-BP to the 
IRE.223.28 '.325.sn Low intracellular iron levels increase the affinity of the IRE-BP for the 
IRE, possibly by changing its rate of degradation.ss, The iron induced changes in 
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affinity may be caused by oxidation and reduction of the IRE-BP .'57 The effects of 
binding of the IRE-BP depend on the location of the IRE in the mRNA. In ferritin 
mRNA the position of the IRE is very critical for its function.""'" 
IRE's are located in the 5' side in ferritin mRNA and in the 3' side in TfR mRNA. 
Dissociation of the IRE-BP stabilizes ferritin mRNA260 and alows it to be translated, 
while TfR mRNA becomes less stable and is degraded more rapidly. The overall 
effect of high intracellular iron levels is, therefore, reduced binding of the IRE-BP to 
the IRE's, leading to increased ferritin and decreased TfR synthesis. Iron shortage 
caused by desferrioxamine gradually increases TfR synthesis.'S9 However, the 
compound in which iron is offered to the cells might affect the impact on mRNA 
translation. Hemin, for instance, also influences ferritin mRNA transcription.70 
In the IRE-hypothesis, the regulation of iron uptake and storage are combined. The 
results described in chapter IV and VI, however, strongly suggest that in cultured 
cytotrophoblasts the regulation of TfR and ferritin synthesis are not controlled strictly 
according to the IRE-hypothesis. Data are required on cytotrophoblast TfR and 
ferritin synthesis to obtain evidence on the role of IRE's in the control of trophoblast 
iron homeostasis and, possibly, in the regulation of transplacental iron transport. 
Apart from the comparison of iron enriched medium to iron poor control medium, 
these experiments should comprise the effects of active withdrawal of cellular iron 
by chelation. 
VII-2. MATERIALS AND METHODS. 
VII-2.1. Cell isolation and culture. 
Cytotrophoblasts were isolated using procedure A as described in Chapter II, and 
cultured for about 18 h in control medium. Culture was continued up to 72 h in 
control medium, medium supplemented with hTf-2Fe (1.25 pM), FAC (10 pg/ml), or 
medium enriched with desferrioxamine (50 pM). At indicated culture times TfR and 
ferritin synthesis was determined as described below. 
90 
VII-2.2. Ferritin, transferrin receptor, and total protein synthesis. 
Transferrin receptor and ferritin synthesis 
Cells were washed twice with icecold PBS. Methionin-free medium was added and 
the cells were incubated for 1 hour at 37°C, followed by 2 hours incubation with 60-
80 pCi translabelled 35S-Methionin (1089 Cijmmol) per 1.5 x 10' cells in methionin 
free medium. The medium was removed and the cells were washed twice w~h PBS. 
The cells were lysed in 300 pi lysate buffer consisting of 1 % Triton X-100, 1mM 
Phenyl-Methyl-Sulfon-Fluoride, 0.5 U/ml aprotinin in PBS (pH 7.4). To remove all 
cell material, the dishes were washed twice with 100 pi lysate buffer. Lysis was 
checked using an inverted microscope. The cell-Iysates were centrifuged for 2 min 
at 10,000 g. 
BSA (400 pg) and L-Methionin (104 times the original 35S-Methionin concentration) 
were added to the supernatants of all the samples. 35S-Methionin labelled ferritin 
was precip'rtated by add~ion of rabbit-anti-human-placental-ferritin-lgG, bound to 
Sepharose-CL4B. '01 35S-Methionin labelled TfRs were precipitated by add~ion of a 
saturating concentration of diferric transferrin bound to Sepharose 4B. Samples 
were gently rotated during 18 hours at 4°C and subsequently centrifuged for 5 min 
at 1200 g. The precip~ates were washed four times w~h a solution containing of 
PBS (pH 7.4), 0.2 % sodiumdesoxycholate, 0.2 % Tr~on X-100, 1mM PMSF, and 1 
mg/ml bovine serum albumin. Equal volumes of electrophoresis sample buffer were 
added to the precipitates (buffer composition: 4ml distilled water, 1ml 0.5 M Tris-HCI 
(pH 6.8), 0.8ml Glycerol, 1.6ml 10 % SDS, O.4ml 2-B-mercaptoethanol, 0.2ml 0.05 % 
bromophenol blue) and the samples were boiled for 10 min. Finally, the samples 
were centrifuged for 2 min at 10,000 g. The supernatants were used for further 
analysis. 
The proteins in 15 pi of the supernatant were separated by polyacrylamide gel 
electrophoresis (200V, 45-60 min) on 12 % (for ferritin) and 15 % (for TfRs) 
homogenous acrylamide/bis gels. Electrophoresis was continued until the 
frontindicator approached the end of the gel. The gels were fixed for 30 min in a 
solution consisting of 10 % acetic acid, 55 % ethanol and 35 % distilled water, and 
subsequently incubated for 15 min in a fluorographic reagent obtained from 
Amersham Nederland BV, (den Bosch, NL). The fixed gels were (vacuum) dried at 
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80°C for 2 hours. Light sensitive films (GBX-2, Kodak) were exposed to the gels for 
4 days up to 2 weeks before fixation. Finally, the autoradiographes were scanned in 
an Ultroscan Xl Enhanced laser Densitometer (lKB, Bromma). 
Total protein synthesis 
Samples for determination of the total protein synthesis were handled as follows. To 
0.02 ml of the cell-lysate 0.1 ml distilled water and 0.1 ml icecold 20 % 
trichloroaceticacid (TCA) was added. The samples were centrifuged for 15 min at 
1500 g and subsequently put on ice. The precipitate was washed with 0.5 ml 10 % 
TCA and vigorously mixed with 0.5 ml Soluene-350. Of the final homogeneous 
sample 0.02 ml was carefully transferred to bottles suitable for liquid-scintilation, and 
10 ml Instagel (Packard) was added. B-radiation was determined in an Isocap 300 
counter (Canberra Packard). In general, efficiency was over 85 %, for which the 
obtained CPM's were corrected. The amount of radiation (DPM) present in the total 
protein precipitate was taken as measure for total protein synthesis. 
VII-2.3. Transferrin receptor and ferritin degradation rates. 
To estimate the rate of degradation of TfRs and ferritin, proteins were labelled using 
the procedure for measurement of the synthesis levels. At 48 h culture time the 
experiment was started. After incubation for 1'h h at 37°C with 35S-labelled 
methionin, the radioactive medium was removed and the cells were washed with 
M199. Subsequently, medium was added, identical to the medium present prior to 
the labelling procedure, supplemented with a 104 times excess of unlabelled 
methionin. At 2, 4, 8, and 24 h after labelling cells were lysed and harvested, and 
TfRs and ferritin were isolated as described above (Ferritin, TfR and total protein 
synthesis). The amount of radioactivity in the isolated proteins was quantified by 
electrophoresis, exposure of the gel to a G6X-2 Kodak film, and densitometry of the 
film as described above for the measurement of TfR and ferritin synthesis. 
VII-2.4. Cellular protein. 
Total cellular protein was measured using the Pierce Micro BSA Reagent (see 
Chapter ll). 
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VII-3. RESULTS. 
Also in the present experiments total cellular protein remained stable, irrespective of 
cell differentiation or culture medium additives, but total protein synthesis decreased 
during culture in desferrioxamine containing medium (to 47 % of the control series 
at 65 h culture). No differences were seen between the total protein synthesis in the 
other series (contrOl, hTf-(2Fe), FAC). 
Figure VII-1 shows the results of three combined experiments on TfR synthesis, in 
relation to total protein synthesis as a function of culture time and culture medium 
composition. Compared to the control series, the introduction of dfferric transferrin 
(hTf-2Fe) to the culture medium significantly decreased TfR synthesis: aT < 0.001 
and aT < 0.02 at 42 hand 66 h respectively. In the FAC series no effect on TfR 
synthesis was seen. In the desferrioxamine series, TfR synthesis was significantly 
increased (aT < 0.001, at 42 h). 
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Figure VII-1. Trophoblast transferrin receptor synthesis. 
Cells were isolated and cultured as described in materials and methods. TfRs were 
labelled using translabelled 3SS-methionine and precipitated using hTf-(2Fe) bound 
to Sepharose-4B (see materials and methods). Shown is the synthesis of TfRs 
related to total protein synthesis. Compared to both the control, and the FAC 
series, TfR synthesis was significantly lower in the hTf-(2Fe) series (aT < 0.02). TfR 
synthesis highly significantly increased in the desferrioxamine series (aT < 0.001). 
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Figure VII-2. Trophoblast ferritin synthesis. 
Cells were isolated and cultured as described in materials and methods. Ferr~in 
synthesis was measured by "S-methionine labelling and immunoprecipitation (see 
materials and methods). Shown is the synthesis of ferritin related to total protein 
synthesis. No effects on ferritin synthesis were seen in the control, the hTf-(2Fe), 
and the desferrioxamine series. Compared to these series, ferritin synthesis was 
significantly increased in the FAC series (ar < 0.001). 
In Figure VII·2 the results are depicted of three experiments on ferritin synthesis. 
Related to total protein synthesis, ferritin synthesis slightly decreased with time and 
showed no statistical Significant differences between the control, the hTf-(2Fe), and 
the desferrioxamine series. In the FAC series, however, ferritin synthesis was 
strongly increased (ar < 0.001). 
Similar to the variation in total placental and trophoblast ferritin L-H subunit ratiOS, 
the ferr~in subunit ratio in newly synthesized ferritin varied with each cell-isolation 
from 0.30 to 1.12. Within each cell-population subunit ratios were stable during 
culture, and did not change upon add~ion of hTf-(2Fe), FAC or desferrioxamine to 
the culture medium (Table VII-1). 
Preliminary results (one experiment) on TfR and ferritin turnover suggested that 
differences in degradation rates were induced by variation of the iron availability 
during culture. The effects of cell-differentiation were not investigated. TfR 
degradation seemed more rapid in cells cultured in iron enriched medium (ContrOl, 
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desferrioxamine: t. 14 h versus hTf-(2Fe) and FAC: t. 9 h). Compared with TfR 
turnover, ferritin degradation was less rapid (t.: 23 h). It was not affected by the 
culture medium iron supplementation, though desferrioxamine increased the rate of 
ferritin degradation markedly (11 h). 
Table VII-1. Trophoblast ferritin subunit synthesis . 
. Cells were isolated and cultured as described in materials and methods. Newly 
synthesized ferritin was labelled during 1'h h, using translabelled 35S-methionine, 
and isolated by immunoprecipitation. Subunits were obtained by reduction of the 
ferritin and separated by electrophoresis. The amount of labelled ferritin subunits 
was measured by exposure of a Kodak film to the gels for about 2 weeks, followed 
by densitometry of the films. To determine ferritin subunit amounts in the samples, 
peak area's were measured and related to total protein synthesis as described in 
materials and methods. 
VII-4. DISCUSSION. 
In various cell-types, cellular iron uptake and storage are regulated by iron 
itself.241.245.281 Major roles in this regulation mechanism are played by the iron 
responsive element (IRE) (a stemloop structure in the mRNA), and the protein 
binding to this structure, the IRE-binding protein (IRE-SP) (reviewed by Hentze).15. 
Iron changes the conformation of the IRE-SP, reducing its affinity for the IRE.'57 Due 
to the location of the IRE, the translation of ferritin mRNA (IRE in the 5' side),''' and 
TfR mRNA (IRE in the 3' side) are differently affected. Dissociation of the IRE-SP 
(high intracellular iron levels) unblocks ferritin mRNA translation, and it becomes 
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increasingly synthesized.32' Under these circumstances TfR mRNA stability is 
reduced and for that reason it is degraded more rapidly.2" Withdrawal of iron 
induces the opposite reaction. Thus, one of the major characteristics of the IRE-
involved regulation of cellular iron homeostasis is the coupling of iron uptake and 
storage in response to iron availability. 
Ferritin subunit ratios in newly synthesized proteins varied but were approximately 1 
and stable during culture (Table VII-1). This indicates that mainly acidic ferritins are 
synthesized, which is in accordance with the results regarding ferritin subunit ratios 
(Figure VI-3). 
TfR and ferritin synthesis in cultured cytotrophoblasts shows discrepancies with the 
IRE-involved reaction pattern upon iron supplementation and withdrawal. 
According to the results obtained in the control series, both TfR and ferritin 
synthesis do not significantly change between 17 hand 66 h of culture (Figure VII-1 
and VII-2), which indicates that there is no effect of cell-differentiation on TfR or 
ferritin synthesis during this period. Since cytotrophoblasts do not express TfRs, TfR 
synthesis is apparently initiated and stabilized within the first 17 h after isolation. A 
stable production of TfRs during cell-differentiation was also suggested by the 
steady increase in surface TfR numbers in cultured cytotrophoblasts (Figure IV-SA). 
The effects of iron supplementation depend on the type of iron form offered, but do 
not match the pattern of TfR and ferritin synthesis as proposed in the IRE-
hypothesis. Transferrin bound iron reduces TfR synthesis, but it does not increase 
the synthesis of ferritin. Iron dissolved as ferricammoniumcitrate, on the other hand, 
leaves TfR synthesis undisturbed, but significantly increases ferritin synthesis. 
Also the cellular reactions on desferrioxamine supplementation of the culture 
medium are inccnsistent with the IRE-hypothesis; TfR synthesis is increased more 
than two fold, without any effects on ferritin synthesis. 
Iron offered as hTf-(2Fe), a physiological form as compared with FAC iron, 
apparently affects the pool of iron accessible for cellular processes. FAC iron 
induces a pool of intracellular iron, inaccessible to the normal physiological cellular 
processes involved in the regulation of iron homeostasis. Similar results have been 
obtained with nitrilotriacetate in mouse lymphocytes.48 The cell can only protect itself 
by increasing its ferritin synthesis. Nevertheless, TfR synthesis is still required, for 
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accessible iron has to be present as well. 
Although the specific effects of hTf-(2Fe), FAG, and desferrioxamine on TfR and 
ferritin synthesis vary, it can be concluded that in syncytiotrophoblasts the synthesis 
of these' two proteins is not simultaneously regulated. EITher TfR synthesis is 
affected (hTf-(2Fe) and desferrioxamine series) or the synthesis of ferritin (FAG 
series). This implicates that an IRE-involved regulation mechanism does at least not 
solely control iron homeostasis by regulation of TfR and ferritin mRNA translation. 
Also for other levels of the TfR synthesis, alternative regulation mechanisms have 
been described." 
It can be questioned whether it is the mode of iron supplementation that causes the 
effects described. Previously, it was shown that the cellular handling of iron 
depends on the iron-compound offered. Iron taken up from nitrilotriacetate, for 
instance, cannot be used for cell proliferation by mouse lymphocytes.4s,298 
The IRE-involved regulation of TfR and ferritin synthesis has been studied in many 
cell types, using unphysiological iron-chelators like hemin, FAG, nitrilotriacetate and 
desferrioxamine. Furthermore, it is remarkable that in all of these studies either TfR 
synthesis or ferritin synthesis has been investigated. Only in K562 cells both the 
regulation of TfR synthesis and ferritin synthesis have been subject of investigation, 
but unfortunately in two separate studies, using hemin and desferrioxamine as 
stimulators of the ferritin and transferrin receptor, respectively.2",260 The effect of 
desferrioxamine in K562 cells is as would be expected. TfR synthesis is increased. 
But how, in these cells, desferrioxamine affects ferritin mRNA translation is still 
unknown. Hemin clearly affects ferritin mRNA translation. In K562 cells, a 
simultaneous effect on TfR-synthesis has to be proven. 
In contrast to the effects on TfR and ferritin synthesis, neither cell differentiation nor 
variation of culture medium iron concentrations changed the catabolism of these 
proteins. Little is known about the degradation rates of both TfRs and ferritin. In the 
majority of the reviews on TfRs and ferritin, degradation as part of cellular protein 
metabolism is ignored. 
To my knowledge there is only one review that mentions half life times for the TfR 
(14 h to 2-3 days).'" Unfortunately, the original articles this review refers to do not 
support these figures. 
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The only article dealing with ferritin kinetics gives 12 h for the half life time of this 
protein.''' The ferritin iron release half time (11 h) was highly ccmparable to the 
ferritin half life time, which suggests that, at least in K562 cells, ferritin has to be 
degraded to release the majority of its iron. A~hough preliminary, the results on TfR 
and ferritin degradation in cytotrophoblasts suggest the presence of a regulation 
mechanism. Irrespective of the form iron was offered in, TfR degradation is more 
rapid in cells cultured in iron enriched medium: 9.5 h versus 14 h in the control and 
desferrioxamine series. In contrast to ferritin synthesis, its degradation seems to be 
affected by a lack of iron, caused by desferrioxamine. 
In conclusion: the regulation of TfR and ferritin synthesis are uncoupled in cultured 
cytotrophoblasts, and possibly the degradation of TfR can be affected by the 
availability of iron. The question remains, whether or not the results described in this 
chapter are compatible with the transport function of these cells. This question will 
be dealt with in Chapter VIII, together with the other resu~ described in this thesis. 
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Chapter VIII. GENERAL CONSIDERATIONS. 
VIII-1. INTRODUCTION. 
Transplacental iron transport is a complicated one-directional process. Ir::ln, 
originally bound to maternal transferrin, is transported to fetal transferrin. On tts way 
from the maternal to the fetal circulation, tt passes through several tissue layers. At 
term, two of these are cell layers. 
The complete transport route is far from understood. Overall transport studies have 
revealed some of tts characteristics The placenta is autonomous in iron uptake,'" 
and the major source of iron is maternal transferrin.'2' In man, iron is passed on to 
the fetus, but the maternal transferrin is not. 'OO Maternal Tf binds to TfRs expressed 
by syncytiotrophoblasts.409 The actual uptake of iron is thought to take place via 
receptor mediated endocytosis,17.69 although data have been published on 
transferrin iron release at the cell-surface membrane.404 
VIII-2. THE PLACENTA AND CULTURED CYTOTROPHOBLASTS. 
As discussed in Chapter III, several models can be used for transplacental transport 
studies. For studies on cellular processes, the in vitro culture of cells is one of the 
more suitable models. 
Two groups of cells suttable for in vitro studies on transplacental iron transport can 
be distinguished. The choriocarcinoma cell-lines (BeWo, JAR) and the freshly 
isolated cytotrophoblasts.211.303 Both cell-types have their (dis)advantages, specially 
in studies on iron metabolism. 
Choriocarcinoma cells proliferate, which implicates that results obtained in different 
experiments are comparable because identical cells are used. BeWo cells do have 
the extra advantage that they can be forced to fuse, to form a syncytium, 
morphologically similar to the placental syncytium in vivo.'" 
Nevertheless, this in vttro model may not be the most suttable for studies on cellular 
iron metabolism. The results of experiments on this subject are difficult to 
extrapolate to the physiological situation since proliferating cells do need an 
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appreciable amount of iron for cell-growth and duplication. 
In culture, freshly isolated cytotrophoblasts spontaneously differentiate into 
syncytiotrophoblast-like structures. This is not only based on morphological but also 
on biochemical criteria.95.211 The major disadvantage of this cell-type is their 
incapability to duplicate and their tendency to die!" Therefore the majority of the 
experiments are carried out in non-identical cells which originate from placentae 
grown under a wide variety of circumstances. Specially maternal anaemia and 
diabetes mellitus might affect cellular iron transport processes'95 
Compared with experiments using BeWo cells, extrapolation to the in vivo situation 
of the results on iron metabolism, obtained with freshly isolated cytotrophoblasts, is 
more reliable. 
One point of interest remains; most of the experiments were started 17-24 h after 
isolation. At that stage cells are still differentiating. Therefore, both cell-differentiation 
and cellular regulating mechanisms for iron metabolism could cause the effects 
observed and should be considered. The possibility that the mechanisms of 
transplacental iron transport mature during pregnancy has not been investigated in 
this thesis. Studies on this subject require first and second trimester placentae 
without fetal pathology. In particular, second trimester placentae are very difficult to 
obtain within half an hour after spontaneous abortion or delivery. 
VIII-3. TRANSFERRIN RECEPTORS IN CYTOTROPHOBLASTS. 
Every step in iron uptake, storage and release by syncytiotrophoblasts is potentially 
available for control mechanisms regulating transplacental iron transport. Not all of 
them (e.g. shedding of TfRs into the maternal circulation, Figure IV-4) , are involved 
in the control of this process. 
In cellular iron uptake, TfRs do play an important role." During in vitro 
differentiation, cytotrophoblasts express TfRs, and surface TfR numbers are affected 
by supplementation of the culture medium with diferric transferrin (hTf-(2Fe)).36 In 
Chapter IV it was shown that surface as well as total TfR numbers steadily increase 
during culture. Addition of hTf-(2Fe) to the culture medium reduces total TfR 
numbers, but does not affect the rate of increase (Figure IV-7). The question arises, 
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Schematic drawing of the processes involved in TfR metabolism. Assuming 
constant, cell·differentiation dependent, TfR DNA transcription, TfR numbers are 
balanced by TfR mRNA translation and TfR degradation rates (thick and thin arrows 
represent high and low rates, respectively). 
Independent of the rate of TfR synthesis and degradation, from the moment on they 
are in balance, the number of TfRs will be stable (B,C). The number of TfRs 
continues to increase, if TfR mRNA translation dominates over TfR degradation (A). 
The opposite occurs, when TfR degradation is more rapid (D). 
if this is caused by (temporarily) decreased TfR synthesis or increased TfR 
degradation until a new equilibrium has been reached (Figure VIII-1). In Chapter VII 
it is shown that TfR synthesis is surely, and TfR degradation might be affected (still 
subject of investigation). 
As depicted in Figure VIII-1, TfR synthesis can potentially be affected at the levels of 
transciption and translation. Regulation of transcription would be possible at the 5' 
and 3' side of the DNA coding for the receptor. The sequences of the 5' side of the 
gene are responsible for the proliferation-dependent regulation of TfR synthesis, 
presumably at the level of transcription (reviewed by Testa, Pelosi and Peschle).387 
An intact 3' side of the gene, coding for the untranslated mRNA lron-Responsive-
Element, is required for the iron controlled regulation of TfR synthesis, at the level of 
translation. Regulation at this level takes place via IRE-binding proteins in the 
cytosol. 
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The following hypothesis for the regulation of TfR expression is based on the 
findings described above. The rate of TfR gene transcription (the production of 
mRNA) is a differentiation-phase dependent process. Once produced, the mRNA 
becomes more stable if cells are cultured in iron poor culture medium. Its turnover 
rate is low and many TfR proteins can be translated prior to its degradation. HTf-
(2Fe) supplementation of the culture medium reduces TfR mRNA stability, the rate 
of degradation is increased and less TfRs are synthesized. Regulation via this 
mechanism is reversible. 
A necessity for this mechanism to function is the availability of an effective 
concentration of IRE-BP, even early in differentiation. If the iron-sulphur protein 
aconitase is the IRE-BP, its permanent presence could easily be explained, because 
aconitase is required for energy production in the Krebs-cycle. 
There is no simple explanation for the difference in effect of hTf-(2Fe) and FAC on 
TfR synthesis. Possibly, the IRE-BP is incapable of binding ammonium citrate 
chelated iron because of its structure and size. Only a part of the iron offered will 
destabilize TfR mRNA and succesfully decrease TfR synthesis. 
VIII-4. IRON UPTAKE AND ITS REGULATION BY CYTOTROPHOBLASTS. 
It is an old dogma that cellular iron needs are reftected in their surface TfR 
densities, and that changes in surface TfR numbers can affect iron uptake rates. 
Therefore, not only the total number of TfRs is important, but also the cellular 
distribution of the receptors. In Figure IV-5 it is shown that in cells cultured in iron 
poor medium surface TfR numbers are increased, which is caused in part by a 
redistribution of TfRs (Figure lV-g). 
The distribution of TfRs is a highly dynamic process. TfRs are distributed among 
functionally different pools localized at the cell surface as well as intracellularly 
(Chapter IV). In particular this latter sub-group of TfRs is intriguing for it rises the 
question in which cellular organelles these receptors are present. 
The receptors actively participating in the endocytic cycle are present at the cell 
surface or in endosomes. Part of these receptors, however, are trafficked into other 
routes (resialylation, degradation). The localization of the inactive TfRs, though 
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capable of binding transferrin, is more unclear. It seems likely that part of these 
receptors is present in the Golgi ccmplex or other organelles involved in protein 
synthesis (reviewed by Stoorvogel et aI., 1991).'69 Another part may be trafficked to 
a basal pool of TfRs participating in an independent receptor cycle"·40' These TfR 
locations may in part explain the 25 to 30 % of receptors not externalized within 1 h. 
The functional implications of basolateral TfRs are not yet understood. Firstly, there 
is no transplacental transport of maternal transferrin, which TfRs could mediate. 
Secondly, if these receptors have identical characteristics as those at the apical 
side, one would expect iron also to be transported to the mother. This is because, 
at term, hTf concentrations in the maternal and fetal circulation are similar, but hTf 
iron saturation is much higher in the fetus (20 % in the mother versus 60 % in the 
fetus). 
The glycosylation of both the TfR,175 and serum Tf have been shown to influence 
affinities.s, There is evidence for considerable interindividual variability in chain 
complexity."7 It has been shown in both guinea pig and human placenta that, 
compared to higher glycosylated transferrins, the affinity for the microvillous plasma 
membrane TfR of less glycosylated transferrins is higher.89.238 Since in the last 
trimester of pregnancy the concentration of high glycosylated transferrin in the fetal 
serum is higher than that in the maternal, it is likely that this reduces the binding of 
transferrin to the basal membrane TfRs, and prevents iron from being transported 
back to the mother. 
Remains the question, to what purpose TfRs are present on the basal membrane. 
For instance, they could be useful, if trophoblasts synthesize transferrin. This could 
be the case because transferrin mRNA has been isolated from placental 
homogenates.'41 If so, a basolateral endocytic cycle cculd participate in the 
externalization of hTf to the fetal Circulation, comparable to the synthesis and 
externalization of transferrin in the liver."4 
Despite the differences in surface TfR numbers, the initial rate of iron uptake does 
not vary in reaction to cell-differentiation or iron enrichment of the culture medium 
(Figure V-1). TfR cycle times are as important as surface TfR densities (Table V-1), 
which implicates that the cellular iron needs are not reflected solely by cell surface 
TfR densities. 
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The uptake rate of iron is regulated by cellular TfR distribution and TfR kinetics. In 
case the cellular iron concentration is low, TfR synthesis is stimulated by 
stabilization of its mRNA More TfRs are trafficked to the cell surface and iron 
uptake would increase if TfR cycle times were not adapted (decreased). By 
combining the regulation of both TfR numbers and cycle times, trophoblasts 
become capable of controlling iron uptake even more precisely than by regulation 
of TfR mRNA translation alone. These mechanisms for regulation of iron uptake 
make syncytiotrophoblasts highly autonomous in iron uptake. 
The effect of TfR gene transcription on TfR numbers and iron uptake by 
syncytiotrophoblasts may be of importance in the long term, but it does not 
contribute to the regulation of iron uptake in the short culture periods used in the 
experiments presented. 
Vill-S. IRE'S AND FERRITIN METABOLISM IN CYTOTROPHOBLASTS. 
If IRE's are involved in the regulation of TfR synthesis, also the synthesis of ferritin 
should be controlled via this system. The effects of hTf-(2Fe), FAC and 
desferrioxamine on TfR and ferritin synthesis, however, do not support this 
hypothesis. Enrichment of the culture medium with one of these additives affects 
either TfR or ferritin synthesis. In particular the decrease in TfR synthesis in reaction 
to hTf-(2Fe) without a simu~aneous increase in ferritin synthesis argues in favour of 
a regulation mechanism for transplacental iron transport independent of the 
regulation of cellular iron homeostasis. 
Ferritin does not take part in the control of transferrin iron transport in a way 
comparable to the situation in the gut, where a surplus of iron is stored in ferritin 
and finally lost in the lumen when mucosal cells are extruded. Nevertheless, ferritin 
can temporarily store iron on its way to the fetus, protecting the cell from damage 
by hydroxyl radicals. 
The absence of an effect on ferritin synthesis of hTf-(2Fe) supplementation of the 
cu~ure medium (Figure VII-2) suggests that ferritin is not used as a vehicle for the 
transfer of iron to the fetal circulation. The main localization of ferritin in 
syncytiotrophoblasts in vivo (close to the apical cell membrane) further supports this 
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hypothesis. 
The effects of FAC on ferritin synthesis (Figure VII-2) and accumulation (Figure VI-5) 
might be explained by the incapability of the cell to cope with this iron form. Since 
its extrusion seems difficult (Figure VI-4), the cell has to protect itself from potentially 
toxic free iron by an increased ferritin synthesis. 
VIII-S. IRON RELEASE BY CYTOTROPHOBLASTS. 
Little is known about cellular iron release mechanisms, not by complete destruction 
of the cell. Since the uptake of iron is regulated between very narrow limits, the 
primary locus for the regulation of syncytiotrophoblasts iron contents could be 
situated in the basal membrane. Regulation of cellular iron extrusion could control 
transplacental iron transport. 
There are experimental results in favour of such a regulation mechanism. Control of 
the transfer of iron across the basal membrane would most likely be sensitive to the 
concentration of iron in the fetal interstitial fluids. It has been shown in cultured 
cytotrophoblasts that replacement of the culture medium increases iron release,94 
and fetectomy causes accumulation of iron in syncytiotrophoblasts.131 .432 Also the 
results on iron accumulation indicate that some kind of iron release mechanism 
matures simultaneously with cell-differentiation (Figure V-2). 
The effects of FAC enrichment of the culture medium suggest that the release of 
iron cannot be adapted to the intracellular iron levels in the short term. This is a 
characteristic of an active transport process, requiring the synthesis of specific 
vehicles, although incapability of the cell to cope with FAC could also explain these 
results. 
Since it is unclear if trophoblasts in culture polarize, and because the experiments 
were performed in one chamber settings, it has to be assumed that for cultured 
cytotrophoblasts the composition of the "maternal" and '~etal" "interstitial fluids" are 
identical. To pursue this hypothesis, cultured cytotrophoblasts might cope with the 
media offered as being fetal fluids. In this respect, it could well be that, it is not the 
maternal blood iron concentration that causes the adaptation of the transport 
system, but the availability of iron in the fetus. 
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SUMMARY. 
Despite the fact that research on the transplacental iron transport has been 
performed for decades, its cellular mechanisms and regulation are far from 
understood. 
An in vitro model became available in 1986, highly specific for the placental 
syncytium formed by syncytiotrophoblasts. Cellular iron transport processes could 
be studied. In this model cytotrophoblasts are isolated. During culture cytotrop-
hob lasts differentiate into syncytiotrophoblast-like cells as among others, concluded 
from transferrin receptor (TfR) expression. TfRs are required for iron uptake since 
transferrin (hTf) is the major iron source of the placenta. Iron, bound to hTf, is taken 
up by the cell via receptor mediated endocytosis. Intracellularly, iron is transferred 
to the cytosol by a process unknown sofar. In the cytosol it is bound to a 'Low-
Molecular-Weight pool', most likely composed of many different molecules. Iron is 
passed on to ferritin and the basal side of the syncytium. The mechanisms involved 
in iron transport across the syncytiotrophoblast basal membrane and through the 
interstitial tissues to the fetal circulation are still unknown. All that has been found is 
that iron in the fetal circulation, iron is bound to fetal transferrin. 
In Chapter I an overview is presented of the current ideas on iron metabolism in 
man and in particular in the placenta. The various proteins involved in chelating iron 
under physiological conditions are discussed, as are the mechanisms of (cellular) 
iron uptake, iron transport in the circulation, and iron storage. Also the 
characteristics of the different placenta types are discussed. Finally, the knowledge 
of placental iron transport is summarized. 
In Chapter II, the required materials and the methods generally used are discussed. 
The procedures of the specific experiments are presented in the matching chapters. 
Chapter 1/1 deals with morphological and biochemical aspects of the in vitro model, 
used in most of the experiments discussed in this thesis. Cytotrophoblasts cultured 
in Medium-199 form aggregates and fuse to form multinuclear structures. During 
106 
this differentiation process, cellular protein and DNA concentrations are stable until 
at least 90 h of culture, although prolonged culture up to 160 h is possible. Cell 
viability is highly dependent on the time loss between delivery of the placenta and 
the start of the isolation procedure. 
During cytotrophoblast differentiation TfRs are expressed. Several characteristics of 
this process are discussed in Chapter IV. Surface and total cellular TfR numbers in 
relation to cell-differentiation are presented as well as TfR shedding and cellular TfR 
distribution. 
Syncytiotrophoblasts do not shed TfRs. Compared with cells cultured in diferric 
transferrin (hTf-(2Fe)) containing medium, the cells cultured in iron poor medium 
increase surface as well as total TfR numbers. 
Two functionally different TfR pools are defined, one active and one inactive. The 
TfRs in the active pool participate in the endocytic cycle, the TfRs of the other pool 
are inactive although capable of binding hTf. Trophoblasts increase the number of 
TfRs in the active pool in reaction to low iron supplies by redistribution of the 
receptors between the active and inactive pool. 
In Chapter V the effects of the variations in surface TfR numbers on trophoblast 
iron uptake are discussed. In~ial iron uptake rates does not differ in reaction to cell-
differentiation nor iron supplementation of the culture medium. This is explained by 
changes in TfR cycle times, which compensate for the number of surface TfRs. 
Using both TfR numbers as well as TfR cycle times as tools for the control of iron 
internalization, the placenta becomes autonomous in iron uptake. It seems likely 
that a mechanism for iron release matures simultaneously with cell-differentiation. 
Chapter VI deals with ferr~in and its possible role in the transplacental transport of 
iron. Trophoblast ferritins are highly enriched w~h H-subunits. Cellular iron and 
ferritin concentrations are not affected by additon of hTf-(2Fe) to the culture 
medium. FAC supplementation of the culture medium, however, increases 
intracellular iron levels and ferritin iron saturation, upon which the cells reacted by 
increasing cellular ferritin concentrations. 
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It is concluded that syncytiotrophoblast can handle hTf bound iron w~hout any 
problem. Iron uptake and release are in balance. Apparently, it is difficult for 
syncytiotrophoblasts to cope with ammoniumcitrate chelated iron. Iron release is 
hampered and the cells can only protect themselves by increasing cellular ferritin 
concentrations in order to store the abundantly present iron. 
The results on TfR and ferritin synthesis (Chapter VII) further support the findings 
on TfR numbers and ferritin concentrations, as described in Chapter IV and Chapter 
VI. Surprisingly, the effects are not completely in accordance with the lron-
Responsive-Element hypothesis, which claims that TfR and ferritin synthesis are 
simultaneously regulated by IRE's and IRE-BP's. HTf-(2Fe) enrichment of the culture 
medium, decreases TfR synthesis but does not affect ferritin synthesis. FAC 
increases ferr~in synthesis but does not influence TfR synthesis. Also the changes 
in synthesis of TfRs 0ncreased) and ferritin (no effect) in reaction to desferrioxamine 
are not consistent w~h the IRE-hypothesis. It is concluded that the simultaneous 
regulation of TfR and ferritin synthesis are uncoupled in syncytiotrophoblasts. It 
could be that the regulatory mechanisms involved, have different sensitivities for 
iron. 
In Chapter VIII the results of the experiments are reviewed in light of the regulation 
of iron transport across the placenta. The hypothesis that the factor controlling 
transplacental iron transport could be localized in the basal membrane has been 
proposed. 
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SAMENVATTING 
Ondanks het feit dat er reeds tientallen jaren onderzoek plaatsvindt naar het 
transplacentair ijzertranspcrt, zijn de betrokken cellulaire mechanismen en de 
regulatie ervan nog verre van begrepen. 
In 1986 kwam een in vitro model beschikbaar, specffiek voor het placentaire 
syncytium dat gevormd wordt door syncytiotrophoblasten. In dit model worden 
cytotrophoblasten, de voorloper cellen van de syncytiotrophoblasten, geTsoleerd en 
gekweekt zodat de cellulaire ijzertransport processen bestudeerd konden worden. 
In kweek differentieren cytotrophoblasten in syncytiotrophoblasten wat onder 
andere geconcludeerd kan worden uit het feit dat ze transferrine receptoren (TfRen) 
tot expressie brengen. TfRen zijn noodzakelijk voor de opname van ijzer omdat 
transferrine (hTf) de belangrijkste bron van ijzer voor de placenta is. IJzer gebonden 
aan hTf, wordt door middel van receptor gemedieerde endocytose opgenomen 
door de cel. Intracellulair wordt het ijzer vanuit de endosomen via een nog 
onbekend proces overgebracht naar het cytosol. Daar wordt het gebonden door 
een pool van laag moleculaire stoffen, de "Low-Moleculair-Weight fraction" en 
uiteindelijk doorgegeven aan ferritine danwel naar de basale zijde van het 
syncytium. 
De mechanismen betrokken bij het transport van ijzer over de basaal membraan en 
door het interstitiele weefsel naar de foetale circulatie, zijn nog volledig onbekend. 
Het enige dat bekend is, is dat ijzer in de foetale circulatie gebonden is aan ijzer. 
In hoofdstuk I is een overzicht gegeven van de huidige ideeen ten aanzien van het 
ijzermetabolisme in de mens en met name de placenta. De diverse eiwitten 
betrokken bij de chelatie van ijzer onder fysiologische omstandigheden en de 
mechanismen van (cellulaire) ijzeropname, van ijzertransport in de circulatie en van 
de opslag van ijzer zijn beschreven. Ook zijn de caracteristieken van de 
verschillende placenta-types besproken. Tenslotte is een samenvatting gegeven van 
de kennis over transplacentair ijzertransport. 
In hoofdstuk II zijn de algemeen gebruikte materialen en methoden besproken. 
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Procedures gebruikt voor specifieke experimenten zijn in de corresponderende 
hoofdstukken gepresenteerd. 
Hoofdstuk III behande~ de morphologische en biochemische aspecten van het in 
de meeste experimenten gebruikte in vitro model. In kweek vormen 
cytotrophoblasten aggregaten waarna ze fuseren tot multinucleaire structuren. 
Tijdens dit differentiatie proces zijn tot zo'n 60 uur na aanvang van de kweek de 
cellulaire eiwit en DNA concentraties nagenoeg stabiel. Langere kweektijden tot 160 
uur zijn desondanks mogelijk, hetgeen vooral afhankelijk is van het tijdsverlies 
tussen geboorte van de placenta en aanvang van de cel-isolatie procedure. 
Tijdens differentiatie komen TfRen tot expressie. Enige characteristieken van dit 
proces komen in hoofdstuk IV ter sprake. Gepresenteerd zijn het aantal TfRen op 
het cel-oppervlak en het totaal aantal cellulaire TfRen in relatie tot cel-differentiatie. 
Tevens zijn de TfR uitscheiding en cellulaire verdeling van TfRen besproken. 
Syncytiotrophoblasten scheiden geen TfRen uit door middel van "shedding". 
Vergeleken met cell en gekweekt in diferric transferrin (hTf-(2Fe)) houdend medium 
verhogen cellen gekweekt in ijzer-arm medium hun oppervlakte zowel als hun totaal 
aantal receptoren. 
Twee functioneel verschillende TfR subgroepen worden gedefinieerd; een aktief en 
sen inaktief. De TfRen in de aktieve subgroep nemen deel aan de endocytose 
cyclus. Hoewel de TfRen in de andere subgroep inaktief zijn kunnen zij wei hTf 
binden. In reaktie op een laag ijzer aanbod verhogen syncytiotrophoblasten het 
aantal TfRen in de aktieve subgroep door middel van herverdeling van de 
receptoren over beide subgroepen. 
In hoofdstuk V is de invloed van de variatie in het aantal TfRen op het celoppervlak 
op de ijzeropname door trophoblasten beschreven. Cel-differentiatie noch ijzer 
aanbod via het kweek medium had enige invloed op de initiele ijzeropname. Dit 
wordt verklaart door het feit dat TfR cyclustijden zodanig aangepast worden dat 
voor het aantal oppervlakte TfRen gecompenseerd wordt. Door zowel TfR aantallen 
als TfR cyclustijden te reguleren wordt de placenta autonoom voor ijzeropname. 
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Waarschijnlijk rijpt er parallel met de cel differentiatie ook een mechanisme uit dat 
de afgifte van ijzer reguleerd. 
Hoofdstuk VI behandelt ferritine en haar mogelijke rol in het transplacentair 
ijzertransport. Trophoblast ferritine is sterk verrijkt met H-ketens. Toevoeging van 
hTf-(2Fe) aan het kweek medium beYnvloed de hoeveelheid cellulair ijzer noch de 
cellulaire ferritine concentratie. Ferricamoniumcitrate (FAC) daarentegen verhoogd 
de cellulaire ijzerconcentratie en de ferritine ijzerverzadiging, waarop de cel reageert 
door de ferritine concentratie ook te verhogen. Geconcludeerd is dat 
syncytiotrophoblasten hTf gebonden ijzer zonder problemen kunnen hanteren en 
dat de ijzeropname in balans is met de afgifte. IJzergebonden aan ammonium citrate 
kan minder makkelijk door de cellen worden verwerkt. Doordat de afgifte van ijzer 
trager verloopt dan de opname zijn de cellen gedwongen om de ferritine 
concentratie te verhogen om zich te beschermen tegen vrije radicalen. 
De resultaten ten aanzien van TfR en ferritine synthese (Hoofdstuk VII) 
ondersteunen de metingen uit hoofdstuk IV en VI. Opvallend is dat de gemeten 
effecten niet volledig in samenspraak zijn met de "Iron Responsive Element 
hypothese, welke inhoud dat TfR en ferritine synthese simultaan gereguleerd 
worden door ijzer. Verrijking van het kweekmedium met hTf-(2Fe) namelijk verlaagt 
TfR synthese maar beYnvloedt de TfR synthese niet. FAC verhoogt de synthese van 
ferritine maar beinvloedt de TfR synthese weer niet. Ook de effekten van 
desferrioxamine op de synthese van TfRen (verhoogd) en ferritine (geen effekt) zijn 
niet conform de IRE-hypothese. Geconcludeerd is dat de parallelle regulatie van TfR 
en ferritine synthese ontkoppelt is in syncytiotrophoblasten. Het is mogelijk dat de 
gevoeligheid van de betrokken regulatiemechanismen voor ijzer verschilt met de 
vorm waarin het ijzer aangeboden wordt. 
In hoofdstuk VIII tenslotte is een overzicht gegeven van de gevonden resultaten in 
verband met het transport van ijzer door de placenta. De hypothese dat het 
contrale mechanisme van het transplacentaire ijzertransport gelegen is in de basaal 
membraan van de syncytiotrophoblast is verder uitgewerkt. 
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